Q2 false--04-29 0000065270 2023 0000065270 us-gaap:TransferredAtPointInTimeMember 2022-05-01 2022-10-29 0000065270 mei:InterfaceMember 2022-10-29 0000065270 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2022-05-01 2022-10-29 0000065270 us-gaap:NetInvestmentHedgingMember 2021-05-02 2021-10-30 0000065270 us-gaap:TransferredAtPointInTimeMember 2021-08-01 2021-10-30 0000065270 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember mei:BankofAmericaNAAndWellsFargoBankNAMember us-gaap:SubsequentEventMember 2022-10-31 0000065270 mei:AutomotiveMember us-gaap:EMEAMember 2022-07-31 2022-10-29 0000065270 us-gaap:OperatingSegmentsMember mei:InterfaceMember 2022-07-31 2022-10-29 0000065270 us-gaap:CustomerRelationshipsMember 2022-04-30 0000065270 srt:ManagementMember us-gaap:RestrictedStockMember mei:A2020EBITDAMaximumPerformanceMember 2022-04-30 0000065270 mei:IndustrialMember us-gaap:EMEAMember 2021-08-01 2021-10-30 0000065270 us-gaap:CommonStockMember 2021-05-01 0000065270 srt:NorthAmericaMember mei:MedicalMember 2021-05-02 2021-10-30 0000065270 mei:MedicalMember 2021-05-02 2021-10-30 0000065270 us-gaap:OperatingSegmentsMember 2021-05-02 2021-10-30 0000065270 us-gaap:AccumulatedTranslationAdjustmentMember 2021-07-31 0000065270 us-gaap:OperatingSegmentsMember 2022-07-31 2022-10-29 0000065270 us-gaap:OperatingSegmentsMember mei:CorporateAndIntersegmentEliminationMember 2021-05-02 2021-10-30 0000065270 us-gaap:IntersegmentEliminationMember 2021-05-02 2021-10-30 0000065270 mei:IndustrialMember us-gaap:TransferredAtPointInTimeMember 2021-08-01 2021-10-30 0000065270 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-04-30 0000065270 us-gaap:NetInvestmentHedgingMember 2022-07-31 2022-10-29 0000065270 us-gaap:AccumulatedTranslationAdjustmentMember 2022-10-29 0000065270 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-31 2022-10-29 0000065270 mei:MedicalMember 2022-10-29 0000065270 mei:IndustrialMember us-gaap:TransferredAtPointInTimeMember 2022-05-01 2022-10-29 0000065270 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-05-01 2022-10-29 0000065270 mei:InterfaceMember 2022-07-31 2022-10-29 0000065270 mei:TradeNamesPatentsAndTechnologyLicencesMember 2022-05-01 2022-10-29 0000065270 us-gaap:CustomerRelationshipsMember 2022-05-01 2022-10-29 0000065270 us-gaap:ForeignExchangeForwardMember 2021-05-02 2021-10-30 0000065270 us-gaap:RetainedEarningsMember 2021-07-31 0000065270 us-gaap:RestrictedStockUnitsRSUMember 2022-05-01 2022-10-29 0000065270 mei:TwoThousandFourteenStockPlanMember 2022-09-14 0000065270 2022-07-31 2022-10-29 0000065270 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember mei:BankOfAmericaNAAdministrativeAgentSwingLineLenderAndLCIssuerAndLendersAndOtherPartiesNamedThereinMember us-gaap:SubsequentEventMember 2022-10-31 0000065270 us-gaap:AdditionalPaidInCapitalMember 2021-05-02 2021-10-30 0000065270 mei:TwoThousandTwentyTwoIncentivePlanMember 2022-05-01 2022-10-29 0000065270 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-10-29 0000065270 us-gaap:AdditionalPaidInCapitalMember 2022-10-29 0000065270 mei:CorporateAndIntersegmentEliminationMember 2022-10-29 0000065270 us-gaap:EMEAMember 2022-07-31 2022-10-29 0000065270 mei:InterfaceMember us-gaap:IntersegmentEliminationMember 2021-08-01 2021-10-30 0000065270 us-gaap:OperatingSegmentsMember mei:InterfaceMember 2021-05-02 2021-10-30 0000065270 mei:CompensatoryDamagesMember 2020-03-02 0000065270 us-gaap:ConstructionInProgressMember 2022-10-29 0000065270 us-gaap:TransferredAtPointInTimeMember 2021-05-02 2021-10-30 0000065270 mei:AutomotiveMember us-gaap:TransferredOverTimeMember 2021-05-02 2021-10-30 0000065270 us-gaap:LandMember 2022-04-30 0000065270 us-gaap:OperatingSegmentsMember mei:InterfaceMember 2021-08-01 2021-10-30 0000065270 srt:AsiaMember mei:AutomotiveMember 2021-08-01 2021-10-30 0000065270 mei:AutomotiveMember 2022-07-31 2022-10-29 0000065270 mei:MedicalMember 2022-07-31 2022-10-29 0000065270 us-gaap:OperatingSegmentsMember mei:InterfaceMember 2022-05-01 2022-10-29 0000065270 mei:CorporateAndIntersegmentEliminationMember 2021-08-01 2021-10-30 0000065270 us-gaap:TransferredOverTimeMember 2022-07-31 2022-10-29 0000065270 mei:TradeNamesPatentsAndTechnologyLicencesMember 2021-05-01 2022-04-30 0000065270 us-gaap:AccumulatedTranslationAdjustmentMember 2022-05-01 2022-10-29 0000065270 us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember 2022-04-30 0000065270 us-gaap:OperatingSegmentsMember mei:AutomotiveMember 2022-07-31 2022-10-29 0000065270 mei:AutomotiveMember 2022-10-29 0000065270 us-gaap:InterestRateSwapMember 2021-08-01 2021-10-30 0000065270 us-gaap:InterestRateSwapMember 2022-10-29 0000065270 mei:DeferredDirectorAwardsMember us-gaap:RestrictedStockUnitsRSUMember mei:TwoThousandFourteenStockPlanMember 2022-05-01 2022-10-29 0000065270 mei:AutomotiveMember us-gaap:IntersegmentEliminationMember 2021-05-02 2021-10-30 0000065270 mei:IndustrialMember us-gaap:IntersegmentEliminationMember 2022-05-01 2022-10-29 0000065270 mei:IndustrialMember 2022-04-30 0000065270 us-gaap:MachineryAndEquipmentMember 2022-04-30 0000065270 mei:IndustrialMember us-gaap:TransferredAtPointInTimeMember 2021-05-02 2021-10-30 0000065270 mei:IndustrialMember srt:NorthAmericaMember 2021-05-02 2021-10-30 0000065270 us-gaap:OperatingSegmentsMember mei:CorporateAndIntersegmentEliminationMember 2022-07-31 2022-10-29 0000065270 mei:OtherDebtMember 2022-04-30 0000065270 us-gaap:TreasuryStockMember 2022-04-30 0000065270 mei:IndustrialMember srt:NorthAmericaMember 2021-08-01 2021-10-30 0000065270 us-gaap:RestrictedStockMember srt:MinimumMember 2022-05-01 2022-10-29 0000065270 mei:TradeNamesPatentsAndTechnologyLicencesMember 2022-10-29 0000065270 us-gaap:OperatingSegmentsMember mei:MedicalMember 2022-05-01 2022-10-29 0000065270 mei:AutomotiveMember us-gaap:IntersegmentEliminationMember 2021-08-01 2021-10-30 0000065270 srt:AsiaMember 2022-07-31 2022-10-29 0000065270 us-gaap:EmployeeStockOptionMember 2022-05-01 2022-10-29 0000065270 mei:TwoThousandFourteenStockPlanMember 2022-07-31 2022-10-29 0000065270 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-10-29 0000065270 srt:AsiaMember mei:AutomotiveMember 2021-05-02 2021-10-30 0000065270 us-gaap:AccumulatedTranslationAdjustmentMember 2022-07-31 2022-10-29 0000065270 us-gaap:ConstructionInProgressMember 2022-04-30 0000065270 mei:CorporateAndIntersegmentEliminationMember 2021-05-02 2021-10-30 0000065270 us-gaap:EMEAMember 2022-05-01 2022-10-29 0000065270 mei:OtherDebtMember 2022-05-01 2022-10-29 0000065270 us-gaap:IntersegmentEliminationMember mei:MedicalMember 2022-05-01 2022-10-29 0000065270 srt:AsiaMember mei:InterfaceMember 2022-07-31 2022-10-29 0000065270 us-gaap:IntersegmentEliminationMember mei:MedicalMember 2021-08-01 2021-10-30 0000065270 2022-07-30 0000065270 us-gaap:ForeignExchangeForwardMember 2022-05-01 2022-10-29 0000065270 us-gaap:TreasuryStockMember 2021-10-30 0000065270 us-gaap:OperatingSegmentsMember mei:IndustrialMember 2021-05-02 2021-10-30 0000065270 mei:IndustrialMember 2022-05-01 2022-10-29 0000065270 us-gaap:CommonStockMember 2021-07-31 0000065270 mei:InterfaceMember us-gaap:TransferredAtPointInTimeMember 2022-05-01 2022-10-29 0000065270 us-gaap:TransferredAtPointInTimeMember 2022-07-31 2022-10-29 0000065270 us-gaap:CommonStockMember 2022-10-29 0000065270 us-gaap:LandMember 2022-10-29 0000065270 mei:IndustrialMember us-gaap:IntersegmentEliminationMember 2021-08-01 2021-10-30 0000065270 us-gaap:InterestRateSwapMember 2021-05-02 2021-10-30 0000065270 us-gaap:MoneyMarketFundsMember 2022-10-29 0000065270 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-07-31 0000065270 srt:MinimumMember us-gaap:BuildingAndBuildingImprovementsMember 2022-05-01 2022-10-29 0000065270 srt:ManagementMember us-gaap:RestrictedStockUnitsRSUMember mei:TwoThousandFourteenStockPlanMember 2022-05-01 2022-10-29 0000065270 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-31 0000065270 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-10-30 0000065270 mei:IndustrialMember us-gaap:IntersegmentEliminationMember 2021-05-02 2021-10-30 0000065270 mei:InterfaceMember 2022-05-01 2022-10-29 0000065270 srt:NorthAmericaMember mei:AutomotiveMember 2021-08-01 2021-10-30 0000065270 us-gaap:RetainedEarningsMember 2022-07-31 2022-10-29 0000065270 mei:Covid19Member 2022-05-01 2022-10-29 0000065270 us-gaap:TreasuryStockMember 2022-10-29 0000065270 us-gaap:OperatingSegmentsMember mei:CorporateAndIntersegmentEliminationMember 2022-05-01 2022-10-29 0000065270 us-gaap:CommonStockMember 2022-04-30 0000065270 us-gaap:EMEAMember 2021-05-02 2021-10-30 0000065270 srt:NorthAmericaMember mei:MedicalMember 2022-07-31 2022-10-29 0000065270 us-gaap:EmployeeStockOptionMember 2021-05-01 2022-04-30 0000065270 us-gaap:RevolvingCreditFacilityMember mei:BankofAmericaNAAndWellsFargoBankNAMember 2022-10-29 0000065270 srt:AsiaMember mei:IndustrialMember 2022-05-01 2022-10-29 0000065270 us-gaap:TransferredOverTimeMember 2021-08-01 2021-10-30 0000065270 srt:AsiaMember 2021-08-01 2021-10-30 0000065270 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember srt:MaximumMember mei:BankOfAmericaNAAdministrativeAgentSwingLineLenderAndLCIssuerAndLendersAndOtherPartiesNamedThereinMember us-gaap:SubsequentEventMember us-gaap:BaseRateMember 2022-10-31 2022-10-31 0000065270 mei:PunitiveDamagesMember 2020-03-02 0000065270 us-gaap:OperatingSegmentsMember mei:AutomotiveMember 2022-05-01 2022-10-29 0000065270 us-gaap:RetainedEarningsMember 2021-08-01 2021-10-30 0000065270 mei:CorporateAndIntersegmentEliminationMember us-gaap:IntersegmentEliminationMember 2021-05-02 2021-10-30 0000065270 mei:InterfaceMember 2022-04-30 0000065270 srt:AsiaMember mei:InterfaceMember 2021-08-01 2021-10-30 0000065270 mei:AutomotiveMember us-gaap:IntersegmentEliminationMember 2022-05-01 2022-10-29 0000065270 mei:AutomotiveMember 2022-05-01 2022-10-29 0000065270 srt:AsiaMember mei:IndustrialMember 2021-05-02 2021-10-30 0000065270 us-gaap:AdditionalPaidInCapitalMember 2022-05-01 2022-10-29 0000065270 mei:OtherDebtMember 2022-10-29 0000065270 us-gaap:MoneyMarketFundsMember 2022-04-30 0000065270 mei:AutomotiveMember us-gaap:EMEAMember 2021-08-01 2021-10-30 0000065270 mei:Covid19Member 2021-08-01 2021-10-30 0000065270 us-gaap:InterestRateSwapMember 2022-05-01 2022-10-29 0000065270 us-gaap:RestrictedStockMember srt:MaximumMember 2022-05-01 2022-10-29 0000065270 us-gaap:CommonStockMember 2021-05-02 2021-10-30 0000065270 srt:AsiaMember 2022-05-01 2022-10-29 0000065270 2021-07-31 0000065270 srt:AsiaMember 2021-05-02 2021-10-30 0000065270 2022-10-29 0000065270 mei:CorporateAndIntersegmentEliminationMember 2022-05-01 2022-10-29 0000065270 mei:MedicalMember us-gaap:TransferredAtPointInTimeMember 2022-05-01 2022-10-29 0000065270 mei:AutomotiveMember 2021-08-01 2021-10-30 0000065270 mei:AutomotiveMember 2022-04-30 0000065270 us-gaap:BuildingAndBuildingImprovementsMember 2022-04-30 0000065270 us-gaap:TreasuryStockMember 2022-07-30 0000065270 srt:AsiaMember mei:InterfaceMember 2021-05-02 2021-10-30 0000065270 us-gaap:IntersegmentEliminationMember 2022-07-31 2022-10-29 0000065270 2021-08-01 2021-10-30 0000065270 srt:NorthAmericaMember mei:AutomotiveMember 2022-05-01 2022-10-29 0000065270 us-gaap:AccumulatedTranslationAdjustmentMember 2022-04-30 0000065270 mei:IndustrialMember us-gaap:EMEAMember 2022-05-01 2022-10-29 0000065270 mei:InterfaceMember us-gaap:TransferredAtPointInTimeMember 2021-08-01 2021-10-30 0000065270 us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:NetInvestmentHedgingMember us-gaap:OtherNoncurrentAssetsMember 2022-10-29 0000065270 us-gaap:TreasuryStockMember 2021-07-31 0000065270 us-gaap:AdditionalPaidInCapitalMember 2021-08-01 2021-10-30 0000065270 srt:NorthAmericaMember mei:MedicalMember 2021-08-01 2021-10-30 0000065270 us-gaap:CommonStockMember 2022-07-31 2022-10-29 0000065270 us-gaap:IntersegmentEliminationMember mei:MedicalMember 2021-05-02 2021-10-30 0000065270 srt:AsiaMember mei:AutomotiveMember 2022-07-31 2022-10-29 0000065270 srt:NorthAmericaMember 2022-05-01 2022-10-29 0000065270 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-07-30 0000065270 us-gaap:OperatingSegmentsMember mei:IndustrialMember 2022-07-31 2022-10-29 0000065270 mei:AutomotiveMember us-gaap:TransferredAtPointInTimeMember 2022-07-31 2022-10-29 0000065270 mei:AutomotiveMember 2021-05-02 2021-10-30 0000065270 mei:MedicalMember 2022-04-30 0000065270 srt:NorthAmericaMember 2021-08-01 2021-10-30 0000065270 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember srt:MaximumMember mei:BankOfAmericaNAAdministrativeAgentSwingLineLenderAndLCIssuerAndLendersAndOtherPartiesNamedThereinMember us-gaap:SubsequentEventMember mei:SecuredOvernightFinancingRateSofrDailyFloatingRateLoansMember 2022-10-31 2022-10-31 0000065270 mei:AutomotiveMember us-gaap:TransferredOverTimeMember 2021-08-01 2021-10-30 0000065270 srt:AsiaMember mei:AutomotiveMember 2022-05-01 2022-10-29 0000065270 us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:NetInvestmentHedgingMember 2022-10-29 0000065270 2021-04-01 2022-10-29 0000065270 srt:AsiaMember mei:InterfaceMember 2022-05-01 2022-10-29 0000065270 us-gaap:RestrictedStockMember srt:DirectorMember 2022-10-29 0000065270 us-gaap:RetainedEarningsMember 2021-10-30 0000065270 2022-11-28 0000065270 us-gaap:CustomerRelationshipsMember 2022-10-29 0000065270 us-gaap:EmployeeStockOptionMember 2022-10-29 0000065270 us-gaap:RetainedEarningsMember 2022-04-30 0000065270 us-gaap:NetInvestmentHedgingMember 2021-08-01 2021-10-30 0000065270 us-gaap:CommonStockMember 2022-07-30 0000065270 us-gaap:RetainedEarningsMember 2022-07-30 0000065270 mei:InterfaceMember us-gaap:IntersegmentEliminationMember 2022-05-01 2022-10-29 0000065270 us-gaap:RestrictedStockMember mei:TwoThousandFourteenStockPlanMember srt:DirectorMember 2022-05-01 2022-10-29 0000065270 2021-10-30 0000065270 mei:AutomotiveMember us-gaap:EMEAMember 2022-05-01 2022-10-29 0000065270 2022-05-01 2022-10-29 0000065270 us-gaap:RestrictedStockUnitsRSUMember 2022-04-30 0000065270 us-gaap:IntersegmentEliminationMember 2022-05-01 2022-10-29 0000065270 us-gaap:RestrictedStockMember srt:DirectorMember 2022-05-01 2022-10-29 0000065270 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-05-01 0000065270 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember mei:BankOfAmericaNAAdministrativeAgentSwingLineLenderAndLCIssuerAndLendersAndOtherPartiesNamedThereinMember us-gaap:SubsequentEventMember 2022-10-31 2022-10-31 0000065270 mei:IndustrialMember srt:NorthAmericaMember 2022-05-01 2022-10-29 0000065270 srt:MaximumMember us-gaap:BuildingAndBuildingImprovementsMember 2022-05-01 2022-10-29 0000065270 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-05-02 2021-10-30 0000065270 srt:NorthAmericaMember mei:MedicalMember 2022-05-01 2022-10-29 0000065270 mei:InterfaceMember 2021-05-02 2021-10-30 0000065270 us-gaap:IntersegmentEliminationMember mei:MedicalMember 2022-07-31 2022-10-29 0000065270 2021-05-01 0000065270 srt:MaximumMember 2021-03-31 0000065270 us-gaap:OperatingSegmentsMember mei:AutomotiveMember 2021-08-01 2021-10-30 0000065270 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-08-01 2021-10-30 0000065270 mei:AutomotiveMember us-gaap:TransferredAtPointInTimeMember 2021-05-02 2021-10-30 0000065270 srt:NorthAmericaMember mei:InterfaceMember 2022-07-31 2022-10-29 0000065270 us-gaap:OperatingSegmentsMember 2021-08-01 2021-10-30 0000065270 us-gaap:TreasuryStockMember 2021-05-01 0000065270 us-gaap:EmployeeStockOptionMember 2022-04-30 0000065270 mei:TwoThousandFourteenStockPlanMember 2021-08-01 2021-10-30 0000065270 mei:IndustrialMember 2021-08-01 2021-10-30 0000065270 mei:MedicalMember us-gaap:TransferredAtPointInTimeMember 2021-05-02 2021-10-30 0000065270 mei:TwoThousandTwentyTwoIncentivePlanMember 2022-10-29 0000065270 us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:NetInvestmentHedgingMember us-gaap:OtherNoncurrentAssetsMember 2022-04-30 0000065270 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember srt:MinimumMember mei:BankOfAmericaNAAdministrativeAgentSwingLineLenderAndLCIssuerAndLendersAndOtherPartiesNamedThereinMember us-gaap:SubsequentEventMember us-gaap:BaseRateMember 2022-10-31 2022-10-31 0000065270 mei:DeferredDirectorAwardsMember us-gaap:RestrictedStockUnitsRSUMember mei:TwoThousandFourteenStockPlanMember 2021-05-02 2021-10-30 0000065270 mei:CorporateAndIntersegmentEliminationMember 2022-07-31 2022-10-29 0000065270 us-gaap:FairValueInputsLevel2Member mei:OtherAccruedLiabilitiesMember us-gaap:NondesignatedMember us-gaap:ForeignExchangeForwardMember 2022-04-30 0000065270 mei:TermLoanMember 2022-10-29 0000065270 us-gaap:NetInvestmentHedgingMember 2022-05-01 2022-10-29 0000065270 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2022-05-01 2022-10-29 0000065270 us-gaap:TransferredOverTimeMember 2022-05-01 2022-10-29 0000065270 us-gaap:RetainedEarningsMember 2021-05-02 2021-10-30 0000065270 srt:NorthAmericaMember 2021-05-02 2021-10-30 0000065270 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember srt:MinimumMember mei:BankOfAmericaNAAdministrativeAgentSwingLineLenderAndLCIssuerAndLendersAndOtherPartiesNamedThereinMember us-gaap:SubsequentEventMember mei:SecuredOvernightFinancingRateSofrDailyFloatingRateLoansMember 2022-10-31 2022-10-31 0000065270 mei:TwoThousandTwentyTwoIncentivePlanMember 2022-09-14 0000065270 us-gaap:AccumulatedTranslationAdjustmentMember 2021-08-01 2021-10-30 0000065270 us-gaap:InterestRateSwapMember 2022-07-31 2022-10-29 0000065270 us-gaap:CommonStockMember 2022-05-01 2022-10-29 0000065270 us-gaap:TradeNamesMember 2022-10-29 0000065270 mei:IndustrialMember us-gaap:TransferredAtPointInTimeMember 2022-07-31 2022-10-29 0000065270 mei:TwoThousandFourteenStockPlanMember 2022-05-01 2022-10-29 0000065270 mei:MedicalMember us-gaap:TransferredAtPointInTimeMember 2021-08-01 2021-10-30 0000065270 us-gaap:TransferredOverTimeMember 2021-05-02 2021-10-30 0000065270 us-gaap:EMEAMember 2021-08-01 2021-10-30 0000065270 srt:NorthAmericaMember 2022-07-31 2022-10-29 0000065270 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-07-31 2022-10-29 0000065270 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-05-01 0000065270 mei:IndustrialMember us-gaap:EMEAMember 2022-07-31 2022-10-29 0000065270 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-30 0000065270 mei:IndustrialMember us-gaap:IntersegmentEliminationMember 2022-07-31 2022-10-29 0000065270 mei:AutomotiveMember us-gaap:TransferredOverTimeMember 2022-05-01 2022-10-29 0000065270 mei:TwoThousandFourteenStockPlanMember 2021-05-02 2021-10-30 0000065270 us-gaap:AdditionalPaidInCapitalMember 2022-07-30 0000065270 us-gaap:ForeignExchangeForwardMember 2021-08-01 2021-10-30 0000065270 us-gaap:AdditionalPaidInCapitalMember 2022-04-30 0000065270 us-gaap:ForeignExchangeForwardMember 2022-10-29 0000065270 us-gaap:AdditionalPaidInCapitalMember 2021-07-31 0000065270 us-gaap:AdditionalPaidInCapitalMember 2022-07-31 2022-10-29 0000065270 us-gaap:RetainedEarningsMember 2021-05-01 0000065270 srt:ManagementMember us-gaap:RestrictedStockMember mei:A2020EBITDAMaximumPerformanceMember 2022-10-29 0000065270 mei:TermLoanMember 2022-04-30 0000065270 mei:InterfaceMember us-gaap:IntersegmentEliminationMember 2022-07-31 2022-10-29 0000065270 us-gaap:OperatingSegmentsMember mei:IndustrialMember 2021-08-01 2021-10-30 0000065270 srt:AsiaMember mei:IndustrialMember 2022-07-31 2022-10-29 0000065270 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-30 0000065270 srt:MaximumMember us-gaap:RestrictedStockUnitsRSUMember 2022-05-01 2022-10-29 0000065270 us-gaap:AdditionalPaidInCapitalMember 2021-10-30 0000065270 srt:NorthAmericaMember mei:AutomotiveMember 2022-07-31 2022-10-29 0000065270 mei:CorporateAndIntersegmentEliminationMember us-gaap:IntersegmentEliminationMember 2021-08-01 2021-10-30 0000065270 mei:MedicalMember us-gaap:TransferredAtPointInTimeMember 2022-07-31 2022-10-29 0000065270 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-08-01 2021-10-30 0000065270 srt:NorthAmericaMember mei:InterfaceMember 2022-05-01 2022-10-29 0000065270 srt:ManagementMember us-gaap:RestrictedStockUnitsRSUMember mei:TwoThousandFourteenStockPlanMember 2021-08-01 2021-10-30 0000065270 mei:InterfaceMember us-gaap:TransferredAtPointInTimeMember 2021-05-02 2021-10-30 0000065270 us-gaap:OperatingSegmentsMember 2022-05-01 2022-10-29 0000065270 us-gaap:OperatingSegmentsMember mei:MedicalMember 2021-08-01 2021-10-30 0000065270 us-gaap:OperatingSegmentsMember mei:MedicalMember 2022-07-31 2022-10-29 0000065270 mei:IndustrialMember 2021-05-02 2021-10-30 0000065270 us-gaap:AccumulatedTranslationAdjustmentMember 2021-05-01 0000065270 us-gaap:FairValueInputsLevel2Member us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:NondesignatedMember us-gaap:ForeignExchangeForwardMember 2022-10-29 0000065270 us-gaap:CommonStockMember 2021-08-01 2021-10-30 0000065270 us-gaap:OperatingSegmentsMember mei:IndustrialMember 2022-05-01 2022-10-29 0000065270 2022-08-16 2022-08-16 0000065270 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-05-02 2021-10-30 0000065270 us-gaap:CommonStockMember 2021-10-30 0000065270 mei:CorporateAndIntersegmentEliminationMember us-gaap:IntersegmentEliminationMember 2022-07-31 2022-10-29 0000065270 us-gaap:ForeignExchangeForwardMember 2022-04-30 0000065270 srt:NorthAmericaMember mei:InterfaceMember 2021-05-02 2021-10-30 0000065270 2022-06-16 0000065270 mei:InterfaceMember us-gaap:IntersegmentEliminationMember 2021-05-02 2021-10-30 0000065270 us-gaap:OperatingSegmentsMember mei:AutomotiveMember 2021-05-02 2021-10-30 0000065270 us-gaap:RestrictedStockMember 2022-10-29 0000065270 mei:MedicalMember 2022-05-01 2022-10-29 0000065270 srt:NorthAmericaMember mei:InterfaceMember 2021-08-01 2021-10-30 0000065270 srt:ManagementMember us-gaap:RestrictedStockUnitsRSUMember mei:TwoThousandFourteenStockPlanMember 2021-05-02 2021-10-30 0000065270 srt:ManagementMember us-gaap:RestrictedStockMember mei:A2020EBITDAMaximumPerformanceMember 2022-05-01 2022-10-29 0000065270 us-gaap:AccumulatedTranslationAdjustmentMember 2021-05-02 2021-10-30 0000065270 2022-04-30 0000065270 mei:AutomotiveMember us-gaap:TransferredOverTimeMember 2022-07-31 2022-10-29 0000065270 us-gaap:OperatingSegmentsMember mei:CorporateAndIntersegmentEliminationMember 2021-08-01 2021-10-30 0000065270 us-gaap:BuildingAndBuildingImprovementsMember 2022-10-29 0000065270 mei:Covid19Member 2022-07-31 2022-10-29 0000065270 us-gaap:FairValueInputsLevel2Member mei:OtherAccruedLiabilitiesMember us-gaap:NondesignatedMember us-gaap:ForeignExchangeForwardMember 2022-10-29 0000065270 us-gaap:RetainedEarningsMember 2022-10-29 0000065270 us-gaap:ForeignExchangeForwardMember 2022-07-31 2022-10-29 0000065270 mei:AutomotiveMember us-gaap:IntersegmentEliminationMember 2022-07-31 2022-10-29 0000065270 srt:AsiaMember mei:IndustrialMember 2021-08-01 2021-10-30 0000065270 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-10-30 0000065270 mei:IndustrialMember us-gaap:EMEAMember 2021-05-02 2021-10-30 0000065270 us-gaap:OperatingSegmentsMember mei:MedicalMember 2021-05-02 2021-10-30 0000065270 us-gaap:AccumulatedTranslationAdjustmentMember 2022-07-30 0000065270 mei:AutomotiveMember us-gaap:TransferredAtPointInTimeMember 2021-08-01 2021-10-30 0000065270 mei:InterfaceMember 2021-08-01 2021-10-30 0000065270 us-gaap:CustomerRelationshipsMember 2021-05-01 2022-04-30 0000065270 srt:ManagementMember us-gaap:RestrictedStockUnitsRSUMember mei:TwoThousandFourteenStockPlanMember 2022-07-31 2022-10-29 0000065270 mei:MedicalMember 2021-08-01 2021-10-30 0000065270 us-gaap:MachineryAndEquipmentMember 2022-10-29 0000065270 mei:IndustrialMember 2022-07-31 2022-10-29 0000065270 us-gaap:RevolvingCreditFacilityMember mei:TermLoanMember mei:BankOfAmericaNAAdministrativeAgentSwingLineLenderAndLCIssuerAndLendersAndOtherPartiesNamedThereinMember us-gaap:SubsequentEventMember 2022-10-31 0000065270 us-gaap:AccumulatedTranslationAdjustmentMember 2021-10-30 0000065270 us-gaap:RestrictedStockMember mei:TwoThousandFourteenStockPlanMember srt:DirectorMember 2021-05-02 2021-10-30 0000065270 mei:IndustrialMember srt:NorthAmericaMember 2022-07-31 2022-10-29 0000065270 mei:CorporateAndIntersegmentEliminationMember 2022-04-30 0000065270 us-gaap:IntersegmentEliminationMember 2021-08-01 2021-10-30 0000065270 us-gaap:RestrictedStockUnitsRSUMember 2022-10-29 0000065270 us-gaap:AdditionalPaidInCapitalMember 2021-05-01 0000065270 mei:TradeNamesPatentsAndTechnologyLicencesMember 2022-04-30 0000065270 srt:NorthAmericaMember mei:AutomotiveMember 2021-05-02 2021-10-30 0000065270 mei:AutomotiveMember us-gaap:EMEAMember 2021-05-02 2021-10-30 0000065270 2021-05-02 2022-04-30 0000065270 mei:AutomotiveMember us-gaap:TransferredAtPointInTimeMember 2022-05-01 2022-10-29 0000065270 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-05-01 2022-10-29 0000065270 us-gaap:TradeNamesMember 2022-04-30 0000065270 mei:CorporateAndIntersegmentEliminationMember us-gaap:IntersegmentEliminationMember 2022-05-01 2022-10-29 0000065270 mei:Covid19Member 2021-05-02 2021-10-30 0000065270 us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:InterestRateSwapMember 2022-10-29 0000065270 mei:InterfaceMember us-gaap:TransferredAtPointInTimeMember 2022-07-31 2022-10-29 0000065270 mei:IndustrialMember 2022-10-29 0000065270 2021-05-02 2021-10-30 0000065270 us-gaap:RetainedEarningsMember 2022-05-01 2022-10-29 mei:Segment iso4217:EUR xbrli:pure mei:Note xbrli:shares iso4217:USD xbrli:shares iso4217:USD

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

(Mark One)

☒ | Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

for the quarterly period ended October 29, 2022

or

☐ | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

for the transition period from ______ to ______

Commission file number 001-33731

METHODE ELECTRONICS, INC.

(Exact name of registrant as specified in its charter)

Delaware | 36-2090085
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.)
8750 West Bryn Mawr Avenue, Suite 1000, Chicago, Illinois | 60631-3518
(Address of principal executive offices) | (Zip Code)

(Registrant’s telephone number, including area code) (708) 867-6777

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each Class |  | Trading Symbol(s) |  | Name of each exchange on which registered
Common Stock, $0.50 Par Value |  | MEI |  | New York Stock Exchange

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer |  | ☒ |  | Accelerated filer |  | ☐
Non-accelerated filer |  | ☐ |  | Smaller reporting company |  | ☐
Emerging growth company |  | ☐ |  |  |  |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Securities Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

At November 28, 2022, the registrant had 36,091,673 shares of common stock outstanding.

Table of Contents

METHODE ELECTRONICS, INC.

IND EX

|  | Page
PART I. | FINANCIAL INFORMATION |
Item 1. | Financial Statements |
| Condensed Consolidated Statements of Income (unaudited) - Three and Six Months Ended October 29, 2022 and October 30, 2021 | 2
| Condensed Consolidated Statements of Comprehensive Income (unaudited) - Three and Six Months Ended October 29, 2022 and October 30, 2021 | 3
| Condensed Consolidated Balance Sheets as of October 29, 2022 (unaudited) and April 30, 2022 | 4
| Condensed Consolidated Statements of Shareholders’ Equity (unaudited) - Three and Six Months Ended October 29, 2022 and October 30, 2021 | 5
| Condensed Consolidated Statements of Cash Flows (unaudited) - Six Months Ended October 29, 2022 and October 30, 2021 | 7
| Notes to Condensed Consolidated Financial Statements | 8
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 22
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 32
Item 4. | Controls and Procedures | 32
PART II. | OTHER INFORMATION |
Item 1A. | Risk Factors | 33
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 33
Item 6. | Exhibits | 33
SIGNATURES | 34

Table of Contents

PART I. FINANCI AL INFORMATION

Item 1. Financ ial Statements

METHODE ELECTRONICS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATE MENTS OF INCOME (Unaudited)

(in millions, except per share data)

|  | Three Months Ended |  |  | Six Months Ended |
|  | October 29, 2022 |  |  | October 30, 2021 |  |  | October 29, 2022 |  |  | October 30, 2021 |
Net sales |  | $ | 315.9 |  |  | $ | 295.5 |  |  | $ | 598.3 |  |  | $ | 583.3 |
Cost of products sold |  |  | 241.8 |  |  |  | 226.3 |  |  |  | 462.4 |  |  |  | 442.4 |
Gross profit |  |  | 74.1 |  |  |  | 69.2 |  |  |  | 135.9 |  |  |  | 140.9 |
Selling and administrative expenses |  |  | 36.6 |  |  |  | 31.2 |  |  |  | 71.9 |  |  |  | 64.0 |
Amortization of intangibles |  |  | 4.7 |  |  |  | 4.8 |  |  |  | 9.4 |  |  |  | 9.6 |
Income from operations |  |  | 32.8 |  |  |  | 33.2 |  |  |  | 54.6 |  |  |  | 67.3 |
Interest expense, net |  |  | 0.5 |  |  |  | 1.1 |  |  |  | 0.5 |  |  |  | 2.2 |
Other income, net |  |  | (1.1 | ) |  |  | (0.9 | ) |  |  | (5.2 | ) |  |  | (2.7 | )
Income before income taxes |  |  | 33.4 |  |  |  | 33.0 |  |  |  | 59.3 |  |  |  | 67.8 |
Income tax expense |  |  | 5.8 |  |  |  | 5.5 |  |  |  | 10.2 |  |  |  | 11.2 |
Net income |  | $ | 27.6 |  |  | $ | 27.5 |  |  | $ | 49.1 |  |  | $ | 56.6 |
Basic and diluted income per share: |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 0.76 |  |  | $ | 0.73 |  |  | $ | 1.35 |  |  | $ | 1.50 |
Diluted |  | $ | 0.75 |  |  | $ | 0.72 |  |  | $ | 1.33 |  |  | $ | 1.48 |
Cash dividends per share |  | $ | 0.14 |  |  | $ | 0.14 |  |  | $ | 0.28 |  |  | $ | 0.28 |

See notes to condensed consolidated financial statements.

2

Table of Contents

METHODE ELECTRONICS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS O F COMPREHENSIVE INCOME (Unaudited)

(in millions)

|  | Three Months Ended |  |  | Six Months Ended |
|  | October 29, 2022 |  |  | October 30, 2021 |  |  | October 29, 2022 |  |  | October 30, 2021 |
Net income |  | $ | 27.6 |  |  | $ | 27.5 |  |  | $ | 49.1 |  |  | $ | 56.6 |
Other comprehensive income (loss), net of tax: |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency translation adjustments |  |  | (19.7 | ) |  |  | (6.6 | ) |  |  | (30.6 | ) |  |  | (10.7 | )
Derivative financial instruments |  |  | 1.6 |  |  |  | 1.7 |  |  |  | 3.1 |  |  |  | 2.6 |
Total comprehensive income |  | $ | 9.5 |  |  | $ | 22.6 |  |  | $ | 21.6 |  |  | $ | 48.5 |

See notes to condensed consolidated financial statements.

3

Table of Contents

METHODE ELECTRONICS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDA TED BALANCE SHEETS

(in millions, except share and per-share data)

|  | October 29, 2022 |  |  | April 30, 2022 |
|  | (unaudited) |  |  |  |
ASSETS |  |  |  |  |  |
Current assets: |  |  |  |  |  |
Cash and cash equivalents |  | $ | 129.6 |  |  | $ | 172.0 |
Accounts receivable, net |  |  | 312.8 |  |  |  | 273.3 |
Inventories |  |  | 172.5 |  |  |  | 158.5 |
Income tax receivable |  |  | 8.2 |  |  |  | 8.3 |
Prepaid expenses and other current assets |  |  | 35.3 |  |  |  | 16.9 |
Total current assets |  |  | 658.4 |  |  |  | 629.0 |
Long-term assets: |  |  |  |  |  |
Property, plant and equipment, net |  |  | 189.6 |  |  |  | 197.0 |
Goodwill |  |  | 231.0 |  |  |  | 233.0 |
Other intangible assets, net |  |  | 196.7 |  |  |  | 207.7 |
Operating lease right-of-use assets, net |  |  | 24.2 |  |  |  | 20.0 |
Deferred tax assets |  |  | 35.4 |  |  |  | 36.8 |
Pre-production costs |  |  | 27.0 |  |  |  | 27.2 |
Other long-term assets |  |  | 32.0 |  |  |  | 38.4 |
Total long-term assets |  |  | 735.9 |  |  |  | 760.1 |
Total assets |  | $ | 1,394.3 |  |  | $ | 1,389.1 |
LIABILITIES AND SHAREHOLDERS' EQUITY |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |
Accounts payable |  | $ | 124.5 |  |  | $ | 108.5 |
Accrued employee liabilities |  |  | 29.9 |  |  |  | 30.0 |
Other accrued liabilities |  |  | 31.0 |  |  |  | 24.5 |
Short-term operating lease liabilities |  |  | 6.3 |  |  |  | 6.0 |
Short-term debt |  |  | 13.0 |  |  |  | 13.0 |
Income tax payable |  |  | 8.3 |  |  |  | 6.6 |
Total current liabilities |  |  | 213.0 |  |  |  | 188.6 |
Long-term liabilities: |  |  |  |  |  |
Long-term debt |  |  | 191.0 |  |  |  | 197.5 |
Long-term operating lease liabilities |  |  | 19.0 |  |  |  | 14.8 |
Long-term income tax payable |  |  | 16.7 |  |  |  | 22.1 |
Other long-term liabilities |  |  | 15.4 |  |  |  | 14.0 |
Deferred tax liabilities |  |  | 40.4 |  |  |  | 38.3 |
Total long-term liabilities |  |  | 282.5 |  |  |  | 286.7 |
Total liabilities |  |  | 495.5 |  |  |  | 475.3 |
Shareholders' equity: |  |  |  |  |  |
Common stock, $0.50 par value, 100,000,000 shares authorized, 37,505,633 shares and 38,276,968 shares issued as of October 29, 2022 and April 30, 2022, respectively |  |  | 18.7 |  |  |  | 19.2 |
Additional paid-in capital |  |  | 174.7 |  |  |  | 169.0 |
Accumulated other comprehensive loss |  |  | (54.3 | ) |  |  | (26.8 | )
Treasury stock, 1,346,624 shares as of October 29, 2022 and April 30, 2022 |  |  | (11.5 | ) |  |  | (11.5 | )
Retained earnings |  |  | 771.2 |  |  |  | 763.9 |
Total shareholders' equity |  |  | 898.8 |  |  |  | 913.8 |
Total liabilities and shareholders' equity |  | $ | 1,394.3 |  |  | $ | 1,389.1 |

See notes to condensed consolidated financial statements.

4

Table of Contents

METHODE ELECTRONICS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS O F SHAREHOLDERS’ EQUITY (Unaudited)

(in millions, except share data)

|  | Three Months Ended October 29, 2022 |
|  | Common stock shares |  |  | Common stock |  |  | Additional paid-in capital |  |  | Accumulated other comprehensive income (loss) |  |  | Treasury stock |  |  | Retained earnings |  |  | Total shareholders' equity |
Balance as of July 30, 2022 |  |  | 38,001,714 |  |  | $ | 19.0 |  |  | $ | 172.0 |  |  | $ | (36.2 | ) |  | $ | (11.5 | ) |  | $ | 768.1 |  |  | $ | 911.4 |
Issuance of restricted stock, net of tax withholding |  |  | 12,098 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Purchases of common stock |  |  | (508,179 | ) |  |  | (0.3 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (19.4 | ) |  |  | (19.7 | )
Stock-based compensation expense |  |  | — |  |  |  | — |  |  |  | 2.7 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 2.7 |
Other comprehensive loss |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (18.1 | ) |  |  | — |  |  |  | — |  |  |  | (18.1 | )
Net income |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 27.6 |  |  |  | 27.6 |
Dividends on common stock |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (5.1 | ) |  |  | (5.1 | )
Balance as of October 29, 2022 |  |  | 37,505,633 |  |  | $ | 18.7 |  |  | $ | 174.7 |  |  | $ | (54.3 | ) |  | $ | (11.5 | ) |  | $ | 771.2 |  |  | $ | 898.8 |

|  | Three Months Ended October 30, 2021 |
|  | Common stock shares |  |  | Common stock |  |  | Additional paid-in capital |  |  | Accumulated other comprehensive income (loss) |  |  | Treasury stock |  |  | Retained earnings |  |  | Total shareholders' equity |
Balance as of July 31, 2021 |  |  | 39,544,645 |  |  | $ | 19.8 |  |  | $ | 161.2 |  |  | $ | 2.9 |  |  | $ | (11.5 | ) |  | $ | 761.9 |  |  | $ | 934.3 |
Purchases of common stock |  |  | (807,516 | ) |  |  | (0.4 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (34.4 | ) |  |  | (34.8 | )
Stock-based compensation expense |  |  | — |  |  |  | — |  |  |  | 2.6 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 2.6 |
Other comprehensive loss |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (4.9 | ) |  |  | — |  |  |  | — |  |  |  | (4.9 | )
Net income |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 27.5 |  |  |  | 27.5 |
Dividends on common stock |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (5.2 | ) |  |  | (5.2 | )
Balance as of October 30, 2021 |  |  | 38,737,129 |  |  | $ | 19.4 |  |  | $ | 163.8 |  |  | $ | (2.0 | ) |  | $ | (11.5 | ) |  | $ | 749.8 |  |  | $ | 919.5 |

See notes to condensed consolidated financial statements.

5

Table of Contents

METHODE ELECTRONICS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (Unaudited) (continued)

(in millions, except share data)

|  | Six Months Ended October 29, 2022 |
|  | Common stock shares |  |  | Common stock |  |  | Additional paid-in capital |  |  | Accumulated other comprehensive income (loss) |  |  | Treasury stock |  |  | Retained earnings |  |  | Total shareholders' equity |
Balance as of April 30, 2022 |  |  | 38,276,968 |  |  | $ | 19.2 |  |  | $ | 169.0 |  |  | $ | (26.8 | ) |  | $ | (11.5 | ) |  | $ | 763.9 |  |  | $ | 913.8 |
Issuance of restricted stock, net of tax withholding |  |  | 54,479 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (0.4 | ) |  |  | (0.4 | )
Purchases of common stock |  |  | (825,814 | ) |  |  | (0.5 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (31.1 | ) |  |  | (31.6 | )
Stock-based compensation expense |  |  | — |  |  |  | — |  |  |  | 5.7 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 5.7 |
Other comprehensive loss |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (27.5 | ) |  |  | — |  |  |  | — |  |  |  | (27.5 | )
Net income |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 49.1 |  |  |  | 49.1 |
Dividends on common stock |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (10.3 | ) |  |  | (10.3 | )
Balance as of October 29, 2022 |  |  | 37,505,633 |  |  | $ | 18.7 |  |  | $ | 174.7 |  |  | $ | (54.3 | ) |  | $ | (11.5 | ) |  | $ | 771.2 |  |  | $ | 898.8 |

|  | Six Months Ended October 30, 2021 |
|  | Common stock shares |  |  | Common stock |  |  | Additional paid-in capital |  |  | Accumulated other comprehensive income (loss) |  |  | Treasury stock |  |  | Retained earnings |  |  | Total shareholders' equity |
Balance as of May 1, 2021 |  |  | 39,644,913 |  |  | $ | 19.8 |  |  | $ | 157.6 |  |  | $ | 6.1 |  |  | $ | (11.5 | ) |  | $ | 746.0 |  |  | $ | 918.0 |
Issuance of restricted stock, net of tax withholding |  |  | 44,245 |  |  |  | 0.1 |  |  |  | (0.1 | ) |  |  | — |  |  |  | — |  |  |  | (0.3 | ) |  |  | (0.3 | )
Exercise of stock options |  |  | 13,000 |  |  |  | — |  |  |  | 0.5 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 0.5 |
Purchases of common stock |  |  | (965,029 | ) |  |  | (0.5 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (41.9 | ) |  |  | (42.4 | )
Stock-based compensation expense |  |  | — |  |  |  | — |  |  |  | 5.8 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 5.8 |
Other comprehensive loss |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (8.1 | ) |  |  | — |  |  |  | — |  |  |  | (8.1 | )
Net income |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 56.6 |  |  |  | 56.6 |
Dividends on common stock |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (10.6 | ) |  |  | (10.6 | )
Balance as of October 30, 2021 |  |  | 38,737,129 |  |  | $ | 19.4 |  |  | $ | 163.8 |  |  | $ | (2.0 | ) |  | $ | (11.5 | ) |  | $ | 749.8 |  |  | $ | 919.5 |

6

Table of Contents

METHODE ELECTRONICS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEME NTS OF CASH FLOWS (Unaudited)

(in millions)

|  | Six Months Ended |
|  | October 29, 2022 |  |  | October 30, 2021 |
Operating activities: |  |  |  |  |  |
Net income |  | $ | 49.1 |  |  | $ | 56.6 |
Adjustments to reconcile net income to net cash provided by operating activities: |  |  |  |  |  |
Depreciation and amortization |  |  | 24.5 |  |  |  | 25.9 |
Stock-based compensation expense |  |  | 6.7 |  |  |  | 6.6 |
Change in cash surrender value of life insurance |  |  | (0.2 | ) |  |  | (0.6 | )
Amortization of debt issuance costs |  |  | 0.3 |  |  |  | 0.3 |
Loss (gain) on sale of property, plant and equipment |  |  | 0.1 |  |  |  | (0.4 | )
Impairment of long-lived assets |  |  | 0.4 |  |  |  | — |
Change in deferred income taxes |  |  | 1.0 |  |  |  | 0.1 |
Other |  |  | 0.2 |  |  |  | 0.1 |
Changes in operating assets and liabilities: |  |  |  |  |  |
Accounts receivable |  |  | (50.6 | ) |  |  | (0.9 | )
Inventories |  |  | (19.5 | ) |  |  | (25.8 | )
Prepaid expenses and other assets |  |  | (15.7 | ) |  |  | (10.5 | )
Accounts payable |  |  | 21.5 |  |  |  | (1.3 | )
Other liabilities |  |  | 10.3 |  |  |  | (13.4 | )
Net cash provided by operating activities |  |  | 28.1 |  |  |  | 36.7 |
Investing activities: |  |  |  |  |  |
Purchases of property, plant and equipment |  |  | (18.0 | ) |  |  | (21.3 | )
Sale of property, plant and equipment |  |  | 3.5 |  |  |  | 0.6 |
Net cash used in investing activities |  |  | (14.5 | ) |  |  | (20.7 | )
Financing activities: |  |  |  |  |  |
Taxes paid related to net share settlement of equity awards |  |  | (0.5 | ) |  |  | (0.3 | )
Repayments of finance leases |  |  | (0.2 | ) |  |  | (0.3 | )
Proceeds from exercise of stock options |  |  | — |  |  |  | 0.5 |
Purchases of common stock |  |  | (31.6 | ) |  |  | (42.5 | )
Cash dividends |  |  | (9.9 | ) |  |  | (10.3 | )
Repayments of borrowings |  |  | (6.5 | ) |  |  | (16.8 | )
Net cash used in financing activities |  |  | (48.7 | ) |  |  | (69.7 | )
Effect of foreign currency exchange rate changes on cash and cash equivalents |  |  | (7.3 | ) |  |  | (2.3 | )
Decrease in cash and cash equivalents |  |  | (42.4 | ) |  |  | (56.0 | )
Cash and cash equivalents at beginning of the period |  |  | 172.0 |  |  |  | 233.2 |
Cash and cash equivalents at end of the period |  | $ | 129.6 |  |  | $ | 177.2 |
Supplemental cash flow information: |  |  |  |  |  |
Cash paid during the period for: |  |  |  |  |  |
Interest |  | $ | 1.4 |  |  | $ | 1.8 |
Income taxes, net of refunds |  | $ | 12.5 |  |  | $ | 19.9 |
Operating lease obligations |  | $ | 4.0 |  |  | $ | 4.5 |

See notes to condensed consolidated financial statements.

7

Table of Contents

METHODE ELECTRONICS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

Note 1. Description of Business and Summary of Significant Accounting Policies

Description of business

Methode Electronics, Inc. (the “Company” or “Methode”) is a leading global supplier of custom engineered solutions with sales, engineering and manufacturing locations in North America, Europe, Middle East and Asia. The Company designs, engineers and produces mechatronic products for Original Equipment Manufacturers (“OEMs”) utilizing its broad range of technologies for user interface, light-emitting diode (“LED”) lighting system, power distribution and sensor applications.

The Company’s solutions are found in the end markets of transportation (including automotive, commercial vehicle, e-bike, aerospace, bus and rail), cloud computing infrastructure, construction equipment, consumer appliance and medical devices.

Impact of the COVID-19 pandemic and supply chain disruptions

The COVID-19 pandemic and the ongoing measures to reduce its spread have negatively impacted the global economy, disrupted consumer and customer demand and global supply chains, and resulted in manufacturing inefficiencies and increased freight costs due to global capacity constraints. As a result of a resurgence of the virus in China and corresponding government lock-down orders, the COVID-19 pandemic had a negative impact on the Company's China operations in the first quarter of fiscal 2023. Future resurgences of the COVID-19 virus or its variants in China or other regions, including corresponding lock-downs or similar government orders, could impact the Company's results of operations.

Various government programs have been enacted to provide assistance to businesses impacted by the COVID-19 pandemic. The amount of assistance the Company received was $0.2 million and $2.1 million in the three months ended October 29, 2022 and October 30, 2021, respectively. The Company received $4.3 million and $4.0 million in the six months ended October 29, 2022 and October 30, 2021, respectively. Government assistance has been reported as other income.

The Company continues to experience increased material and logistics costs, labor shortages, and most significantly, impacts from the worldwide semiconductor supply shortage. The semiconductor supply shortage is due, in part, to increased demand across multiple industries, including the automotive industry, resulting in a slowdown in production schedules. The semiconductor supply shortage is also impacting the Company’s supply chain and its ability to meet demand at some of its non-automotive customers.

The Russia-Ukraine military conflict has negatively impacted the Company's European customers and suppliers. Although the Company does not have any operations in Russia or Ukraine, certain of its customers and suppliers have been negatively impacted by these events, which in turn has impacted markets where the Company conducts business, including Europe and Asia. The economic sanctions imposed by the international community have further increased existing supply chain, logistics, and inflationary challenges.

Basis of presentation

The unaudited condensed consolidated financial statements of the Company have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). All intercompany balances and transactions have been eliminated in consolidation. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted pursuant to such rules and regulations. These interim condensed consolidated financial statements include all adjustments (consisting of normal recurring adjustments, except as otherwise disclosed) that management believes are necessary for a fair presentation of the results of operations, financial position and cash flows of the Company for the interim periods presented. These financial statements should be read in conjunction with the consolidated financial statements included in the Company’s Form 10-K for the year ended April 30, 2022, filed with the SEC on June 23, 2022. Results may vary from quarter to quarter for reasons other than seasonality.

Financial reporting periods

The Company maintains its financial records on the basis of a 52- or 53-week fiscal year ending on the Saturday closest to April 30. The three months ended October 29, 2022 and October 30, 2021 were both 13-week periods, and the six months ended October 29, 2022 and October 30, 2021 were both 26-week periods.

8

Table of Contents

Use of estimates

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results could differ from these estimates.

Summary of significant accounting policies

The Company’s significant accounting policies are described in Note 1, “Description of Business and Summary of Significant Accounting Policies,” to the consolidated financial statements included in the Company’s Form 10-K for the year ended April 30, 2022. There have been no material changes to the significant accounting policies in the six months ended October 29, 2022.

New accounting pronouncements not yet adopted

In November 2021, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2021-10, “Government Assistance (Topic 832),” which requires annual disclosures when an entity has received government assistance. This guidance is intended to improve the transparency of government assistance received by requiring disclosure of: (1) the types of government assistance received; (2) the accounting for such assistance; and (3) the effect of the assistance on the registrant’s financial statements. The Company will adopt this standard effective April 29, 2023 and expects the standard to only impact annual financial statement footnote disclosures.

Note 2. Revenue

The Company generates revenue from the manufacturing of products for customers in diversified global markets. The substantial majority of the Company’s revenue is recognized at a point in time. The Company has determined that the most definitive demonstration that control of the product has transferred to a customer is physical shipment or delivery, depending on the contractual shipping terms, except for consignment transactions. Consignment transactions are arrangements where the Company transfers product to a customer location but retains ownership and control of the product until it is used by the customer. Revenue for consignment arrangements is recognized upon the customer’s usage.

Revenue associated with products which the Company believes have no alternative use (such as highly customized parts), and where the Company has an enforceable right to payment, are recognized on an over time basis. Revenue is recognized based on progress to date, which is typically even over the production process through transfer of control to the customer.

From time to time, customers may negotiate annual price downs. Management has evaluated these price downs and determined that in some instances, these price downs give rise to a material right. In instances that a material right exists, a portion of the transaction price is allocated to the material right and recognized over the life of the contract.

Across all products, the amount of revenue recognized corresponds to the related purchase order and is adjusted for variable consideration (such as discounts). Sales and other taxes collected concurrent with revenue-producing activities are excluded from revenue.

The Company’s performance obligations are typically short-term in nature. As a result, the Company has elected the practical expedient that provides an exemption from the disclosure requirements regarding information about remaining performance obligations on contracts that have original expected durations of one year or less.

Contract balances

A contract asset is an entity’s right to consideration in exchange for goods or services that the entity has transferred to a customer. A contract liability exists when an entity has received consideration, or the amount is due from the customer in advance of revenue recognition. The net changes in the contract asset and contract liability balances for the six months ended October 29, 2022 and October 30, 2021 were not material.

9

Table of Contents

Disaggregated revenue information

The following table represents a disaggregation of revenue from contracts with customers by segment and geographical location. Net sales are attributed to regions based on the location of production. Though revenue recognition patterns and contracts are generally consistent, the amount, timing and uncertainty of revenue and cash flows may vary in each reportable segment due to geographic and economic factors.

|  | Three Months Ended October 29, 2022 |
(in millions) |  | Automotive |  |  | Industrial |  |  | Interface |  |  | Medical |  |  | Total |
Geographic net sales: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
North America |  | $ | 97.8 |  |  | $ | 40.1 |  |  | $ | 14.0 |  |  | $ | 1.1 |  |  | $ | 153.0 |
Europe, the Middle East & Africa ("EMEA") |  |  | 53.9 |  |  |  | 37.9 |  |  |  | — |  |  |  | — |  |  |  | 91.8 |
Asia |  |  | 45.2 |  |  |  | 25.8 |  |  |  | 0.1 |  |  |  | — |  |  |  | 71.1 |
Total net sales |  | $ | 196.9 |  |  | $ | 103.8 |  |  | $ | 14.1 |  |  | $ | 1.1 |  |  | $ | 315.9 |
Timing of revenue recognition: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Goods transferred at a point in time |  | $ | 192.3 |  |  | $ | 103.8 |  |  | $ | 14.1 |  |  | $ | 1.1 |  |  | $ | 311.3 |
Goods transferred over time |  |  | 4.6 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 4.6 |
Total net sales |  | $ | 196.9 |  |  | $ | 103.8 |  |  | $ | 14.1 |  |  | $ | 1.1 |  |  | $ | 315.9 |

|  | Three Months Ended October 30, 2021 |
(in millions) |  | Automotive |  |  | Industrial |  |  | Interface |  |  | Medical |  |  | Total |
Geographic net sales: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
North America |  | $ | 99.3 |  |  | $ | 42.1 |  |  | $ | 17.8 |  |  | $ | 0.8 |  |  | $ | 160.0 |
EMEA |  |  | 54.9 |  |  |  | 23.4 |  |  |  | — |  |  |  | — |  |  |  | 78.3 |
Asia |  |  | 41.8 |  |  |  | 15.2 |  |  |  | 0.2 |  |  |  | — |  |  |  | 57.2 |
Total net sales |  | $ | 196.0 |  |  | $ | 80.7 |  |  | $ | 18.0 |  |  | $ | 0.8 |  |  | $ | 295.5 |
Timing of revenue recognition: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Goods transferred at a point in time |  | $ | 189.2 |  |  | $ | 80.7 |  |  | $ | 18.0 |  |  | $ | 0.8 |  |  | $ | 288.7 |
Goods transferred over time |  |  | 6.8 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 6.8 |
Total net sales |  | $ | 196.0 |  |  | $ | 80.7 |  |  | $ | 18.0 |  |  | $ | 0.8 |  |  | $ | 295.5 |

|  | Six Months Ended October 29, 2022 |
(in millions) |  | Automotive |  |  | Industrial |  |  | Interface |  |  | Medical |  |  | Total |
Geographic net sales: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
North America |  | $ | 192.5 |  |  | $ | 80.8 |  |  | $ | 27.0 |  |  | $ | 1.8 |  |  | $ | 302.1 |
EMEA |  |  | 106.0 |  |  |  | 66.4 |  |  |  | — |  |  |  | — |  |  |  | 172.4 |
Asia |  |  | 75.0 |  |  |  | 48.7 |  |  |  | 0.1 |  |  |  | — |  |  |  | 123.8 |
Total net sales |  | $ | 373.5 |  |  | $ | 195.9 |  |  | $ | 27.1 |  |  | $ | 1.8 |  |  | $ | 598.3 |
Timing of revenue recognition: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Goods transferred at a point in time |  | $ | 364.4 |  |  | $ | 195.9 |  |  | $ | 27.1 |  |  | $ | 1.8 |  |  | $ | 589.2 |
Goods transferred over time |  |  | 9.1 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 9.1 |
Total net sales |  | $ | 373.5 |  |  | $ | 195.9 |  |  | $ | 27.1 |  |  | $ | 1.8 |  |  | $ | 598.3 |

|  | Six Months Ended October 30, 2021 |
(in millions) |  | Automotive |  |  | Industrial |  |  | Interface |  |  | Medical |  |  | Total |
Geographic net sales: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
North America |  | $ | 198.4 |  |  | $ | 84.5 |  |  | $ | 30.3 |  |  | $ | 1.6 |  |  | $ | 314.8 |
EMEA |  |  | 112.7 |  |  |  | 43.2 |  |  |  | — |  |  |  | — |  |  |  | 155.9 |
Asia |  |  | 80.7 |  |  |  | 31.5 |  |  |  | 0.4 |  |  |  | — |  |  |  | 112.6 |
Total net sales |  | $ | 391.8 |  |  | $ | 159.2 |  |  | $ | 30.7 |  |  | $ | 1.6 |  |  | $ | 583.3 |
Timing of revenue recognition: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Goods transferred at a point in time |  | $ | 378.9 |  |  | $ | 159.2 |  |  | $ | 30.7 |  |  | $ | 1.6 |  |  | $ | 570.4 |
Goods transferred over time |  |  | 12.9 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 12.9 |
Total net sales |  | $ | 391.8 |  |  | $ | 159.2 |  |  | $ | 30.7 |  |  | $ | 1.6 |  |  | $ | 583.3 |

10

Table of Contents

Note 3. Income Taxes

The provision for income taxes for an interim period is based on an estimated annual effective income tax rate applied to ordinary year-to-date earnings or losses. The estimated annual effective income tax rate is determined excluding the effects of unusual or significant one-time items that are reported net of the related tax effects in the period in which they occur. In addition, any material effects of enacted tax law or rate changes as well as the Company’s ability to utilize various tax assets is recognized in the period in which the change occurs.

The computation of the estimated annual effective income tax rate at each interim period requires certain estimates and assumptions including, but not limited to, the expected pre-tax income (or loss) for the year by jurisdiction, certain book to tax adjustments, and the likelihood of the realizability of deferred tax assets generated in the current year. The estimates used to compute the provision or benefit for income taxes may change as new events occur, additional information is obtained or as the Company’s tax environment changes.

The Company’s income tax expense and effective tax rate for the three and six months ended October 29, 2022 and October 30, 2021 were as follows:

|  | Three Months Ended |  |  | Six Months Ended |
($ in millions) |  | October 29, 2022 |  |  | October 30, 2021 |  |  | October 29, 2022 |  |  | October 30, 2021 |
Income before income taxes |  | $ | 33.4 |  |  | $ | 33.0 |  |  | $ | 59.3 |  |  | $ | 67.8 |
Income tax expense |  | $ | 5.8 |  |  | $ | 5.5 |  |  | $ | 10.2 |  |  | $ | 11.2 |
Effective tax rate |  |  | 17.4 | % |  |  | 16.7 | % |  |  | 17.2 | % |  |  | 16.5 | %

The effective tax rate for the three and six months ended October 29, 2022 was lower than the U.S. statutory tax rate primarily due to income derived from foreign operations with lower statutory tax rates and research deductions claimed in foreign jurisdictions, partially offset by non-deductible expenses. The effective tax rate for the three and six months ended October 30, 2021 was lower than the U.S. statutory tax rate primarily due to income derived from foreign operations with lower statutory tax rates.

The Company’s gross unrecognized income tax benefits were $5.2 million and $5.1 million as of October 29, 2022 and April 30, 2022, respectively. If any portion of the Company’s unrecognized tax benefits is recognized, it would impact the Company’s effective tax rate. The unrecognized tax benefits are reviewed periodically and adjusted for changing facts and circumstances, such as tax audits, the lapsing of applicable statutes of limitations and changes in tax law. The Company recognizes interest and penalties related to income tax uncertainties in income tax expense. Accrued interest and penalties were $0.3 million and $0.2 million as of October 29, 2022 and April 30, 2022, respectively.

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was enacted in the United States. The IR Act imposes a 1% excise tax on the fair market value of stock repurchases made by covered corporations after December 31, 2022. The total taxable value of shares repurchased is reduced by the fair market value of any newly issued shares during the taxable year. The Company is assessing the potential impact of the stock repurchase excise tax, but based on its preliminary assessment, the Company does not expect a material impact on its consolidated financial statements. Further, the remaining corporate tax changes included in the IR Act are not expected to have a material impact on the Company’s consolidated financial statements.

Note 4. Balance Sheet Components

Cash and cash equivalents

Cash and cash equivalents consist of cash and highly liquid investments with maturities of three months or less. Highly liquid investments include money market funds which are classified within Level 1 of the fair value hierarchy. As of October 29, 2022 and April 30, 2022, the Company had a balance of $33.3 million and $40.0 million, respectively, in money market accounts.

Accounts receivable and allowance for doubtful accounts

Accounts receivable are customer obligations due under normal trade terms and are presented net of an allowance for doubtful accounts. The Company establishes an allowance for doubtful accounts based on the current expected credit loss impairment model. The Company applies a historical loss rate based on historic write-offs to aging categories. The historical loss rate is adjusted for current conditions and reasonable and supportable forecasts of future losses as necessary. The Company may also record a specific reserve for individual accounts when it becomes aware of specific customer circumstances, such as in the case of a bankruptcy filing or deterioration in the customer’s operating results or financial position. The allowance for doubtful accounts balance was $1.3 million and $1.0 million as of October 29, 2022 and April 30, 2022, respectively.

11

Table of Contents

Inventories

Inventories are stated at the lower-of-cost or net realizable value. Cost is determined using the first-in, first-out method. Finished products and work-in-process inventories include direct material costs and direct and indirect manufacturing costs. The Company records reserves for inventory that may be obsolete or in excess of current and future market demand. A summary of inventories is shown below:

(in millions) |  | October 29, 2022 |  |  | April 30, 2022 |
Finished products |  | $ | 36.6 |  |  | $ | 31.8 |
Work in process |  |  | 15.0 |  |  |  | 12.9 |
Raw materials |  |  | 120.9 |  |  |  | 113.8 |
Total inventories |  | $ | 172.5 |  |  | $ | 158.5 |

Property, plant and equipment

Property, plant and equipment is stated at cost. Maintenance and repair costs are expensed as incurred. Depreciation is calculated using the straight-line method using estimated useful lives of 5 to 40 years for buildings and building improvements and 3 to 15 years for machinery and equipment. A summary of property, plant and equipment is shown below:

(in millions) |  | October 29, 2022 |  |  | April 30, 2022 |
Land |  | $ | 2.9 |  |  | $ | 3.3 |
Buildings and building improvements |  |  | 83.9 |  |  |  | 89.2 |
Machinery and equipment |  |  | 397.0 |  |  |  | 407.5 |
Construction in progress |  |  | 32.3 |  |  |  | 21.5 |
Total property, plant and equipment, gross |  |  | 516.1 |  |  |  | 521.5 |
Less: accumulated depreciation |  |  | (326.5 | ) |  |  | (324.5 | )
Property, plant and equipment, net |  | $ | 189.6 |  |  | $ | 197.0 |

Depreciation expense was $7.5 million and $8.5 million in the three months ended October 29, 2022 and October 30, 2021, respectively. Depreciation expense was $15.1 million and $16.3 million in the six months ended October 29, 2022 and October 30, 2021, respectively. As of October 29, 2022 and April 30, 2022, capital expenditures recorded in accounts payable totaled $5.1 million and $4.4 million, respectively.

Pre-production tooling costs related to long-term supply arrangements

The Company incurs pre-production tooling costs related to products produced for its customers under long-term supply arrangements. Engineering, testing and other costs incurred in the design and development of production parts are expensed as incurred, unless the costs are reimbursable by the customer. As of October 29, 2022 and April 30, 2022, the Company had $27.0 million and $27.2 million, respectively, of pre-production tooling costs related to customer-owned tools for which reimbursement is contractually guaranteed by the customer or for which the customer has provided a non-cancelable right to use the tooling.

Costs for molds, dies and other tools used in products produced for its customers under long-term supply arrangements for which the Company has title are capitalized in property, plant and equipment and amortized over the shorter of the life of the arrangement or the estimated useful life of the assets. As of October 29, 2022 and April 30, 2022, Company-owned tooling was $13.1 million and $14.6 million, respectively.

Note 5. Goodwill and Other Intangible Assets

Goodwill

Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired in a business combination. A summary of the changes in the carrying amount of goodwill, by segment, is shown below:

(in millions) |  | Automotive |  |  | Industrial |  |  | Total |
Balance as of April 30, 2022 |  | $ | 105.9 |  |  | $ | 127.1 |  |  | $ | 233.0 |
Foreign currency translation |  |  | (0.3 | ) |  |  | (1.7 | ) |  |  | (2.0 | )
Balance as of October 29, 2022 |  | $ | 105.6 |  |  | $ | 125.4 |  |  | $ | 231.0 |

The Company tests goodwill and indefinite-lived intangible assets for impairment on an annual basis as of the beginning of the fourth quarter each fiscal year. In addition, the Company continuously monitors for events and circumstances that could negatively impact the key assumptions used in determining fair value and therefore require interim goodwill impairment testing, including long-term revenue growth projections, profitability, discount rates, volatility in the Company's market capitalization, and general industry, market and macroeconomic conditions. No impairment indicators were identified in the six months ended October 29, 2022.

12

Table of Contents

Other intangible assets, net

Details of identifiable intangible assets are shown below:

|  | As of October 29, 2022 |
(in millions) |  | Gross |  |  | Accumulated amortization |  |  | Net |  |  | Weighted average useful life (years) |
Amortized intangible assets: |  |  |  |  |  |  |  |  |  |  |  |
Customer relationships and agreements |  | $ | 230.4 |  |  | $ | (61.0 | ) |  | $ | 169.4 |  |  |  | 14.2 |
Trade names, patents and technology licenses |  |  | 57.5 |  |  |  | (32.0 | ) |  |  | 25.5 |  |  |  | 5.8 |
Total amortized intangible assets |  |  | 287.9 |  |  |  | (93.0 | ) |  |  | 194.9 |  |  |  |
Unamortized trade name |  |  | 1.8 |  |  |  | — |  |  |  | 1.8 |  |  |  |
Total other intangible assets |  | $ | 289.7 |  |  | $ | (93.0 | ) |  | $ | 196.7 |  |  |  |

|  | As of April 30, 2022 |
(in millions) |  | Gross |  |  | Accumulated amortization |  |  | Net |  |  | Weighted average useful life (years) |
Amortized intangible assets: |  |  |  |  |  |  |  |  |  |  |  |
Customer relationships and agreements |  | $ | 232.3 |  |  | $ | (55.1 | ) |  | $ | 177.2 |  |  |  | 14.7 |
Trade names, patents and technology licenses |  |  | 58.0 |  |  |  | (29.3 | ) |  |  | 28.7 |  |  |  | 6.2 |
Total amortized intangible assets |  |  | 290.3 |  |  |  | (84.4 | ) |  |  | 205.9 |  |  |  |
Unamortized trade name |  |  | 1.8 |  |  |  | — |  |  |  | 1.8 |  |  |  |
Total other intangible assets |  | $ | 292.1 |  |  | $ | (84.4 | ) |  | $ | 207.7 |  |  |  |

Based on the current amount of intangible assets subject to amortization, the estimated aggregate amortization expense for each of the five succeeding fiscal years and thereafter is as follows:

(in millions) |  |  |
Fiscal Year: |  |  |
Remainder of 2023 |  | $ | 9.3 |
2024 |  |  | 18.4 |
2025 |  |  | 17.8 |
2026 |  |  | 16.9 |
2027 |  |  | 16.3 |
Thereafter |  |  | 116.2 |
Total |  | $ | 194.9 |

Note 6. Derivative Instruments and Hedging Activities

The Company is exposed to various market risks including, but not limited to, foreign currency exchange rates and market interest rates. The Company strives to control its exposure to these risks through our normal operating activities and, where appropriate, through the use of derivative financial instruments. Derivative financial instruments are measured at fair value on a recurring basis.

For a designated cash flow hedge, the effective portion of the change in the fair value of the derivative financial instrument is recorded in accumulated other comprehensive income (“AOCI”) in the condensed consolidated balance sheets. When the underlying hedged transaction is realized, the gain or loss previously included in AOCI is recorded in earnings and reflected in the condensed consolidated statements of income on the same line as the gain or loss on the hedged item attributable to the hedged risk. The gain or loss associated with changes in the fair value of derivatives not designated as hedges are recorded immediately in the condensed consolidated statements of income on the same line as the associated risk. For a designated net investment hedge, the effective portion of the change in the fair value of the derivative financial instrument is recorded as a cumulative translation adjustment in AOCI in the condensed consolidated balance sheets.

13

Table of Contents

Net investment hedges

The Company has a variable-rate, cross-currency swap, maturing on August 31, 2023, with a notional value of $60.0 million (€54.8 million). The Company entered into the cross-currency swap to mitigate changes in net assets due to changes in U.S. dollar-euro spot exchange rates. The cross-currency swap is designated as a hedge of the Company’s net investment in a euro-based subsidiary.

Hedge effectiveness is assessed at the inception of the hedging relationship and quarterly thereafter, under the spot-to-spot method. The Company recognizes the impact of all other changes in fair value of the derivative, which represents the interest rate differential of the cross-currency swap, through interest expense. For the three months ended October 29, 2022 and October 30, 2021, the Company recorded gains of $0.6 million and $0.1 million, respectively, in interest expense, net in the condensed consolidated statements of income. For the six months ended October 29, 2022 and October 30, 2021, the Company recorded gains of $0.9 million and $0.1 million, respectively, in interest expense, net in the condensed consolidated statements of income.

Interest rate swaps

The Company has interest rate swaps, maturing on August 31, 2023, with a notional value of $100.0 million, to manage its exposure to, and to mitigate the impact of, interest rate variability. The interest rate swaps are designated as cash flow hedges.

Hedge effectiveness is assessed at the inception of the hedging relationship and quarterly thereafter. The effective portion of the periodic changes in fair value is recognized in AOCI in the condensed consolidated balance sheets. Subsequently, the accumulated gains and losses recorded in AOCI are reclassified to income in the period during which the hedged cash flow impacts earnings, which are expected to be immaterial over the next 12 months. No ineffectiveness was recognized in the three or six months ended October 29, 2022 or October 30, 2021.

Derivatives not designated as hedges

The Company uses short-term foreign currency forward contracts to reduce the earnings impact that exchange rate fluctuations have on non-functional currency balance sheet exposures. These forward contracts are not designated as hedging instruments. Gains and losses on these forward contracts are recognized in other income, net, along with the foreign currency gains and losses on monetary assets and liabilities, in the condensed consolidated statements of income.

As of October 29, 2022 and April 30, 2022, the Company held foreign currency forward contracts with a notional value of $62.6 million and $38.6 million, respectively. During the three and six months ended October 29, 2022, the Company recognized a loss of $2.4 million and $2.8 million, respectively, related to foreign currency forward contracts in the condensed consolidated statements of income. During both the three and six months ended October 30, 2021, a gain of $0.3 million was recognized in the condensed consolidated statements of income.

Fair value of derivative instruments on the balance sheet

The fair value of derivative instruments are classified as Level 2 within the fair value hierarchy and are recorded in the balance sheets as follows:

|  |  |  | Asset/(Liability) |
(in millions) |  | Financial Statement Caption |  | October 29, 2022 |  |  | April 30, 2022 |
Derivatives designated as hedging instruments: |  |  |  |  |  |  |  |
Net investment hedges |  | Prepaid expenses and other current assets |  | $ | 5.3 |  |  | $ | — |
Net investment hedges |  | Other long-term assets |  | $ | — |  |  | $ | 1.9 |
Interest rate swaps |  | Prepaid expenses and other current assets |  | $ | 3.7 |  |  | $ | — |
Interest rate swaps |  | Other long-term assets |  | $ | — |  |  | $ | 3.0 |
Derivatives not designated as hedging instruments: |  |  |  |  |  |  |  |
Foreign currency forward contracts |  | Prepaid expenses and other current assets |  | $ | 0.1 |  |  | $ | — |
Foreign currency forward contracts |  | Other accrued liabilities |  | $ | (0.8 | ) |  | $ | (0.2 | )

Effect of derivative instruments on comprehensive income (loss)

Gross amounts recorded in other comprehensive income (loss) were as follows:

|  | Three Months Ended |  |  | Six Months Ended |
(in millions) |  | October 29, 2022 |  |  | October 30, 2021 |  |  | October 29, 2022 |  |  | October 30, 2021 |
Net investment hedges |  | $ | 1.4 |  |  | $ | 1.6 |  |  | $ | 3.4 |  |  | $ | 2.8 |
Interest rate swaps |  |  | 0.7 |  |  |  | 0.7 |  |  |  | 0.7 |  |  |  | 0.6 |

14

Table of Contents

Total |  | $ | 2.1 |  |  | $ | 2.3 |  |  | $ | 4.1 |  |  | $ | 3.4 |

Note 7. Debt

A summary of debt is shown below:

(in millions) |  | October 29, 2022 |  |  | April 30, 2022 |
Term loan |  | $ | 200.0 |  |  | $ | 206.3 |
Other debt |  |  | 4.6 |  |  |  | 5.1 |
Unamortized debt issuance costs |  |  | (0.6 | ) |  |  | (0.9 | )
Total debt |  |  | 204.0 |  |  |  | 210.5 |
Less: current maturities |  |  | (13.0 | ) |  |  | (13.0 | )
Total long-term debt |  | $ | 191.0 |  |  | $ | 197.5 |

Revolving credit facility/term loan

On October 31, 2022, the Company entered into a Second Amended and Restated Credit Agreement (the “Credit Agreement”) among the Company, Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, and the Lenders and other parties named therein. The Credit Agreement amends and restates the Amended and Restated Credit Agreement, dated September 12, 2018 and as previously amended (the “Prior Credit Agreement”), among the Company, Bank of America, N.A., as Administrative Agent, Swing Line Lender, and L/C Issuer, Wells Fargo Bank, National Association, as L/C Issuer, and the Lenders named therein. Among other things, the Credit Agreement (i) increased the multicurrency revolving credit commitments under the Prior Credit Agreement to $750,000,000, (ii) refinanced in full and terminated the term loan facility under the Prior Credit Agreement, and (iii) made certain other changes to the covenants, terms, and conditions under the Prior Credit Agreement. In addition, the Credit Agreement permits the Company to increase the revolving commitments and/or add one or more tranches of term loans under the Credit Agreement from time to time by up to an amount equal to (i) $250,000,000 plus (ii) an additional amount so long as the leverage ratio would not exceed 3.00:1.00 on a pro forma basis, subject to, among other things, the receipt of additional commitments from existing and/or new lenders. The Credit Agreement terminates on October 31, 2027.

Loans denominated in US dollars under the Credit Agreement bear interest at either (a) an adjusted base rate or (b) an adjusted term Secured Overnight Financing Rate (“SOFR”) rate or term SOFR daily floating rate (in each case, as determined in accordance with the provisions of the Credit Agreement) in each case plus an applicable margin (the “Applicable Margin”) ranging between 0.375% and 1.25%, in the case of adjusted base rate loans, and between 1.375% and 2.25%, in the case of adjusted term SOFR rate loans and term SOFR daily floating rate loans. The Applicable Margin is set based on the Company’s consolidated leverage ratio.

In connection with the Credit Agreement, the Company incurred debt issuance costs of approximately $3.2 million which will be capitalized and, along with the current unamortized debt issuance costs of $0.6 million, will be amortized into interest expense over the term of the Credit Agreement.

The weighted-average interest rate on outstanding borrowings under the Prior Credit Agreement was approximately 4.4% as of October 29, 2022. The Prior Credit Agreement contained customary representations and warranties, financial covenants, restrictive covenants and events of default. As of October 29, 2022, the Company was in compliance with all the covenants in the Prior Credit Agreement.

Other debt

One of the Company’s European subsidiaries has debt that consists of three notes with maturities ranging from 2023 to 2031. The weighted-average interest rate on this debt was approximately 1.4% at October 29, 2022 and $0.5 million of the debt was classified as short-term.

15

Table of Contents

Note 8. Shareholders’ Equity

Share buyback program

On March 31, 2021, the Board of Directors authorized the purchase of up to $100.0 million of the Company’s outstanding common stock through March 31, 2023. On June 16, 2022, the Board of Directors authorized an increase in the share buyback program of an additional $100.0 million, and extended the expiration of the program to June 14, 2024. Purchases may be made in private transactions or on the open market, including pursuant to purchase plans designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.

The following table summarizes the Company’s stock buyback activity under this share buyback program:

|  | Three Months Ended |  |  | Six Months Ended |
(in millions, except share and per share data) |  | October 29, 2022 |  |  | October 30, 2021 |  |  | October 29, 2022 |  |  | October 30, 2021 |
Shares purchased |  |  | 508,179 |  |  |  | 807,516 |  |  |  | 825,814 |  |  |  | 965,029 |
Average price per share |  | $ | 38.69 |  |  | $ | 43.07 |  |  | $ | 38.21 |  |  | $ | 43.93 |
Total cost |  | $ | 19.7 |  |  | $ | 34.8 |  |  | $ | 31.6 |  |  | $ | 42.4 |

As of October 29, 2022, a total of 2,418,953 shares have been purchased at a total cost of $102.8 million since the commencement of the share buyback program. All purchased shares were retired and are reflected as a reduction of common stock for the par value of shares, with the excess applied as a reduction to retained earnings. As of October 29, 2022, the dollar value of shares that remained available to be purchased by the Company under this share buyback program was $97.2 million.

Dividends

The Company paid dividends totaling $4.9 million and $5.1 million in the three months ended October 29, 2022 and October 30, 2021, respectively. The Company paid dividends totaling $9.9 million and $10.3 million in the six months ended October 29, 2022 and October 30, 2021, respectively.

Accumulated other comprehensive income (loss)

Comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. A summary of changes in AOCI, net of tax is shown below:

|  | Three Months Ended October 29, 2022 |  |  | Six Months Ended October 29, 2022 |
(in millions) |  | Currency translation adjustments |  |  | Derivative instruments |  |  | Total |  |  | Currency translation adjustments |  |  | Derivative instruments |  |  | Total |
Balance at beginning of period |  | $ | (41.4 | ) |  | $ | 5.2 |  |  | $ | (36.2 | ) |  | $ | (30.5 | ) |  | $ | 3.7 |  |  | $ | (26.8 | )
Other comprehensive income (loss) |  |  | (19.9 | ) |  |  | 2.1 |  |  |  | (17.8 | ) |  |  | (30.8 | ) |  |  | 4.1 |  |  |  | (26.7 | )
Tax (expense) benefit |  |  | 0.2 |  |  |  | (0.5 | ) |  |  | (0.3 | ) |  |  | 0.2 |  |  |  | (1.0 | ) |  |  | (0.8 | )
Net other comprehensive income (loss) |  |  | (19.7 | ) |  |  | 1.6 |  |  |  | (18.1 | ) |  |  | (30.6 | ) |  |  | 3.1 |  |  |  | (27.5 | )
Balance at the end of period |  | $ | (61.1 | ) |  | $ | 6.8 |  |  | $ | (54.3 | ) |  | $ | (61.1 | ) |  | $ | 6.8 |  |  | $ | (54.3 | )

|  | Three Months Ended October 30, 2021 |  |  | Six Months Ended October 30, 2021 |
(in millions) |  | Currency translation adjustments |  |  | Derivative instruments |  |  | Total |  |  | Currency translation adjustments |  |  | Derivative instruments |  |  | Total |
Balance at beginning of period |  | $ | 7.4 |  |  | $ | (4.5 | ) |  | $ | 2.9 |  |  | $ | 11.5 |  |  | $ | (5.4 | ) |  | $ | 6.1 |
Other comprehensive income (loss) |  |  | (6.7 | ) |  |  | 2.3 |  |  |  | (4.4 | ) |  |  | (10.6 | ) |  |  | 3.4 |  |  |  | (7.2 | )
Tax (expense) benefit |  |  | 0.1 |  |  |  | (0.6 | ) |  |  | (0.5 | ) |  |  | (0.1 | ) |  |  | (0.8 | ) |  |  | (0.9 | )
Net other comprehensive income (loss) |  |  | (6.6 | ) |  |  | 1.7 |  |  |  | (4.9 | ) |  |  | (10.7 | ) |  |  | 2.6 |  |  |  | (8.1 | )
Balance at the end of period |  | $ | 0.8 |  |  | $ | (2.8 | ) |  | $ | (2.0 | ) |  | $ | 0.8 |  |  | $ | (2.8 | ) |  | $ | (2.0 | )

16

Table of Contents

Stock-based compensation

On September 14, 2022, the Company's stockholders approved the Methode Electronics, Inc. 2022 Omnibus Incentive Plan (“2022 Plan”). After that date, no further awards can be granted under the Methode Electronics, Inc. 2014 Omnibus Incentive Plan (“2014 Plan”). The 2022 Plan provides for discretionary grants of stock options, stock appreciation rights (“SARs”), restricted stock, restricted stock units and performance grants to employees and directors.

Subject to adjustment as provided in the 2022 Plan and the 2022 Plan’s share counting provisions, the number of shares of the Company's common stock that will be available for all awards under the 2022 Plan is 5,550,000, less one share for every one share of common stock subject to an option or SAR award granted after April 30, 2022 under the 2014 Plan and 2.28 shares for every one share that was subject to an award other than an option or SAR granted after April 30, 2022 under the 2014 Plan. As of October 29, 2022, there were 5,244,232 shares available for award under the 2022 Plan.

The Company has granted stock options, restricted stock awards (“RSAs”), performance units (“PUs”), restricted stock units (“RSUs”) and stock awards to employees and non-employee directors under the 2022 Plan, the 2014 Plan, the Methode Electronics, Inc. 2010 Stock Plan (“2010 Plan”), the Methode Electronics, Inc. 2007 Stock Plan (“2007 Plan”) and the Methode Electronics, Inc. 2004 Stock Plan (“2004 Plan”). The Company can no longer make grants under the 2014 Plan, 2010 Plan, 2007 Plan and 2004 Plan.

Restricted stock awards and performance units

As of October 29, 2022, the Company had 949,674 RSAs outstanding which may be earned based on the achievement of an earnings before net interest, taxes, fixed asset depreciation and intangible asset amortization (“EBITDA”) measure for fiscal 2025. The RSAs will vest ranging from 0% (for performance below threshold) to 100% (target performance) based on the achievement of the EBITDA performance measure and continued employment. In addition, if the target performance is exceeded, up to an additional 474,837 PUs can be earned that will be settled in cash. At the discretion of the Compensation Committee, the PUs may be settled in shares of common stock.

The fair value of the RSAs was based on the closing stock price on the date of grant and the RSAs earn dividend equivalents during the vesting period, which are forfeitable if the RSAs do not vest. Compensation expense for the RSAs is recognized when it is probable the minimum threshold performance criteria will be achieved. Compensation expense for the PUs is recognized when it is probable that the target performance criteria will be exceeded. The Company assesses the probability of vesting at each balance sheet date and adjusts compensation costs based on the probability assessment. The cash-settled PUs represent a non-equity unit with a conversion value equal to the fair market value of a share of the Company’s common stock on the vesting date. The PUs are classified as liability awards due to the cash settlement feature and are re-measured at each balance sheet date. In accordance with Accounting Standards Codification 718, based on projections of the Company’s current business portfolio, no compensation expense has been recognized for the RSAs or PUs to date, as the performance conditions are not probable of being met. Unrecognized stock-based compensation expense at target level of performance is $27.3 million as of October 29, 2022, which, subject to the performance conditions being met, will be recognized through fiscal 2025.

The following table summarizes RSA activity:

|  | Restricted stock awards |  |  | Weighted average grant date fair value |
Non-vested at April 30, 2022 |  |  | 928,412 |  |  | $ | 28.50 |
Awarded |  |  | 21,262 |  |  | $ | 38.41 |
Vested |  |  | — |  |  | $ | — |
Forfeited |  |  | — |  |  | $ | — |
Non-vested at October 29, 2022 |  |  | 949,674 |  |  | $ | 28.72 |

17

Table of Contents

Restricted stock units

RSUs granted vest over a pre-determined period of time, up to five years from the date of grant. The fair value of the RSUs granted are based on the closing stock price on the date of grant and earn dividend equivalents during the vesting periods, which are forfeitable if the RSUs don’t vest.

The following table summarizes RSU activity:

|  | Restricted stock units |  |  | Weighted average grant date fair value |
Non-vested at April 30, 2022 |  |  | 936,391 |  |  | $ | 29.16 |
Awarded |  |  | 73,292 |  |  | $ | 39.10 |
Vested |  |  | — |  |  | $ | — |
Forfeited |  |  | (734 | ) |  | $ | 48.41 |
Non-vested at October 29, 2022 |  |  | 1,008,949 |  |  | $ | 29.87 |

Under the various stock plans, common stock underlying vested RSUs held by certain executives will not be delivered until termination of employment or a change of control of the Company. As of October 29, 2022, common stock to be delivered to these executives totaled 577,055 shares.

Director awards

The Company grants stock awards to its non-employee directors as a component of their compensation. The stock awards vest immediately upon grant. Non-employee directors may elect to defer receipt of their shares under the Company’s non-qualified deferred compensation plan. In the six months ended October 29, 2022, the Company granted 43,043 shares, of which 27,503 shares were deferred. All dividends on deferred shares are reinvested into additional deferred shares based on the closing price of the Company’s common stock on the dividend payment date. Deferred shares will be settled with shares of common stock upon each director’s retirement from the Company’s Board of Directors. As of October 29, 2022, there were 45,459 deferred shares outstanding.

Stock options

The following table summarizes stock option activity:

|  | Stock options |  |  | Weighted average exercise price |  |  | Weighted- average life (years) |  |  | Aggregate intrinsic value (in millions) |
Outstanding and exercisable at April 30, 2022 |  |  | 60,000 |  |  | $ | 37.01 |  |  |  | 2.2 |  |  | $ | 0.5 |
Exercised |  |  | — |  |  | $ | — |  |  |  |  |  |  |
Forfeited |  |  | — |  |  | $ | — |  |  |  |  |  |  |
Outstanding and exercisable at October 29, 2022 |  |  | 60,000 |  |  | $ | 37.01 |  |  |  | 1.7 |  |  | $ | 0.2 |

The aggregate intrinsic value represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price on the last trading day of the period and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on that date.

Stock-based compensation expense

All stock-based awards to employees and non-employee directors are recognized in selling and administrative expenses on the condensed consolidated statements of income. Awards subject to graded vesting are recognized using the accelerated recognition method over the requisite service period. The table below summarizes the stock-based compensation expense related to the equity awards:

|  | Three Months Ended |  |  | Six Months Ended |
(in millions) |  | October 29, 2022 |  |  | October 30, 2021 |  |  | October 29, 2022 |  |  | October 30, 2021 |
RSUs |  | $ | 2.7 |  |  | $ | 2.6 |  |  | $ | 5.1 |  |  | $ | 5.1 |
Deferred director awards |  |  | — |  |  |  | — |  |  |  | 1.0 |  |  |  | 0.8 |
Director awards |  |  | — |  |  |  | — |  |  |  | 0.6 |  |  |  | 0.7 |
Total stock-based compensation expense |  | $ | 2.7 |  |  | $ | 2.6 |  |  | $ | 6.7 |  |  | $ | 6.6 |

18

Table of Contents

Note 9. Income per Share

Basic income per share is calculated by dividing net income by the weighted average number of common shares outstanding for the applicable period but excludes any contingently issued shares where the contingency has not been resolved. The weighted average number of common shares used in the diluted income per share calculation is determined using the treasury stock method which includes the effect of all potential dilutive common shares outstanding during the period.

The following table sets forth the computation of basic and diluted income per share:

|  | Three Months Ended |  |  | Six Months Ended |
|  | October 29, 2022 |  |  | October 30, 2021 |  |  | October 29, 2022 |  |  | October 30, 2021 |
Numerator: |  |  |  |  |  |  |  |  |  |  |  |
Net income (in millions) |  | $ | 27.6 |  |  | $ | 27.5 |  |  | $ | 49.1 |  |  | $ | 56.6 |
Denominator: |  |  |  |  |  |  |  |  |  |  |  |
Denominator for basic income per share - weighted average shares outstanding and vested/unissued restricted stock units |  |  | 36,126,132 |  |  |  | 37,544,357 |  |  |  | 36,346,054 |  |  |  | 37,741,923 |
Dilutive potential common shares |  |  | 715,699 |  |  |  | 538,899 |  |  |  | 682,762 |  |  |  | 528,684 |
Denominator for diluted income per share |  |  | 36,841,831 |  |  |  | 38,083,256 |  |  |  | 37,028,816 |  |  |  | 38,270,607 |
Basic and diluted income per share: |  |  |  |  |  |  |  |  |  |  |  |
Basic income per share |  | $ | 0.76 |  |  | $ | 0.73 |  |  | $ | 1.35 |  |  | $ | 1.50 |
Diluted income per share |  | $ | 0.75 |  |  | $ | 0.72 |  |  | $ | 1.33 |  |  | $ | 1.48 |
Number of anti-dilutive potentially issuable shares excluded from diluted common shares outstanding |  |  | 940,510 |  |  |  | 928,412 |  |  |  | 934,522 |  |  |  | 928,412 |

Note 10. Segment Information

An operating segment is defined as a component of an enterprise that engages in business activities from which it may earn revenues and incur expenses, and about which separate financial information is regularly evaluated by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources. The CODM is the Company’s President and Chief Executive Officer. The Company has four reporting segments as described below.

The Automotive segment supplies electronic and electro-mechanical devices and related products to automobile OEMs, either directly or through their tiered suppliers. Products include integrated center consoles, hidden switches, ergonomic switches, transmission lead-frames, LED-based lighting and sensors, which incorporate magneto-elastic sensing and other technologies that monitor the operation or status of a component or system.

The Industrial segment manufactures external lighting solutions, industrial safety radio remote controls, braided flexible cables, current-carrying laminated busbars and devices, custom power-product assemblies, such as our PowerRail® solution, high-current low-voltage flexible power cabling systems and powder-coated busbars that are used in various markets and applications, including aerospace, computers, industrial, power conversion, military, telecommunications and transportation.

The Interface segment provides a variety of copper and fiber-optic interface and interface solutions for the appliance, commercial food service, construction, consumer, material handling, point-of-sale and telecommunications markets. Solutions include copper transceivers and solid-state field-effect consumer touch panels.

The Medical segment is made up of the Company’s medical device business, Dabir Surfaces, with its surface support technology aimed at pressure injury prevention. Methode has developed the technology for use by patients who are immobilized or otherwise at risk for pressure injuries, including patients undergoing long-duration surgical procedures.

19

Table of Contents

The tables below present information about the Company’s reportable segments:

|  | Three Months Ended October 29, 2022 |
(in millions) |  | Automotive |  |  | Industrial |  |  | Interface |  |  | Medical |  |  | Eliminations /Corporate |  |  | Consolidated |
Net sales |  | $ | 198.3 |  |  | $ | 107.8 |  |  | $ | 14.1 |  |  | $ | 1.1 |  |  | $ | (5.4 | ) |  | $ | 315.9 |
Transfers between segments |  |  | (1.4 | ) |  |  | (4.0 | ) |  |  | — |  |  |  | — |  |  |  | 5.4 |  |  |  | — |
Net sales to unaffiliated customers |  | $ | 196.9 |  |  | $ | 103.8 |  |  | $ | 14.1 |  |  | $ | 1.1 |  |  | $ | — |  |  | $ | 315.9 |
Income (loss) from operations |  | $ | 23.4 |  |  | $ | 25.0 |  |  | $ | 1.6 |  |  | $ | (1.4 | ) |  | $ | (15.8 | ) |  | $ | 32.8 |
Interest expense, net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.5 |
Other income, net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (1.1 | )
Income before income taxes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 33.4 |

|  | Three Months Ended October 30, 2021 |
(in millions) |  | Automotive |  |  | Industrial |  |  | Interface |  |  | Medical |  |  | Eliminations /Corporate |  |  | Consolidated |
Net sales |  | $ | 197.1 |  |  | $ | 82.7 |  |  | $ | 18.0 |  |  | $ | 0.8 |  |  | $ | (3.1 | ) |  | $ | 295.5 |
Transfers between segments |  |  | (1.1 | ) |  |  | (2.0 | ) |  |  | — |  |  |  | — |  |  |  | 3.1 |  |  |  | — |
Net sales to unaffiliated customers |  | $ | 196.0 |  |  | $ | 80.7 |  |  | $ | 18.0 |  |  | $ | 0.8 |  |  | $ | — |  |  | $ | 295.5 |
Income (loss) from operations |  | $ | 23.6 |  |  | $ | 18.8 |  |  | $ | 4.4 |  |  | $ | (1.8 | ) |  | $ | (11.8 | ) |  | $ | 33.2 |
Interest expense, net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1.1 |
Other income, net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (0.9 | )
Income before income taxes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 33.0 |

|  | Six Months Ended October 29, 2022 |
(in millions) |  | Automotive |  |  | Industrial |  |  | Interface |  |  | Medical |  |  | Eliminations /Corporate |  |  | Consolidated |
Net sales |  | $ | 375.6 |  |  | $ | 201.5 |  |  | $ | 27.1 |  |  | $ | 1.8 |  |  | $ | (7.7 | ) |  | $ | 598.3 |
Transfers between segments |  |  | (2.1 | ) |  |  | (5.6 | ) |  |  | — |  |  |  | — |  |  |  | 7.7 |  |  |  | — |
Net sales to unaffiliated customers |  | $ | 373.5 |  |  | $ | 195.9 |  |  | $ | 27.1 |  |  | $ | 1.8 |  |  | $ | — |  |  | $ | 598.3 |
Income (loss) from operations |  | $ | 38.1 |  |  | $ | 47.4 |  |  | $ | 3.2 |  |  | $ | (2.9 | ) |  | $ | (31.2 | ) |  | $ | 54.6 |
Interest expense, net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.5 |
Other income, net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (5.2 | )
Income before income taxes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 59.3 |

|  | Six Months Ended October 30, 2021 |
(in millions) |  | Automotive |  |  | Industrial |  |  | Interface |  |  | Medical |  |  | Eliminations /Corporate |  |  | Consolidated |
Net sales |  | $ | 394.1 |  |  | $ | 163.9 |  |  | $ | 30.7 |  |  | $ | 1.6 |  |  | $ | (7.0 | ) |  | $ | 583.3 |
Transfers between segments |  |  | (2.3 | ) |  |  | (4.7 | ) |  |  | — |  |  |  | — |  |  |  | 7.0 |  |  |  | — |
Net sales to unaffiliated customers |  | $ | 391.8 |  |  | $ | 159.2 |  |  | $ | 30.7 |  |  | $ | 1.6 |  |  | $ | — |  |  | $ | 583.3 |
Income (loss) from operations |  | $ | 50.9 |  |  | $ | 39.0 |  |  | $ | 5.5 |  |  | $ | (3.0 | ) |  | $ | (25.1 | ) |  | $ | 67.3 |
Interest expense, net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2.2 |
Other income, net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (2.7 | )
Income before income taxes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 67.8 |

(in millions) |  | October 29, 2022 |  |  | April 30, 2022 |
Identifiable assets: |  |  |  |  |  |
Automotive |  | $ | 700.6 |  |  | $ | 689.8 |
Industrial |  |  | 463.7 |  |  |  | 455.3 |
Interface |  |  | 113.2 |  |  |  | 108.1 |
Medical |  |  | 6.5 |  |  |  | 7.9 |
Eliminations/Corporate |  |  | 110.3 |  |  |  | 128.0 |
Total identifiable assets |  | $ | 1,394.3 |  |  | $ | 1,389.1 |

20

Table of Contents

Note 11. Contingencies

Certain litigation arising in the normal course of business is pending against us. The Company is, from time-to-time, subject to various legal actions and claims incidental to our business, including those arising out of alleged defects, breach of contracts, employment-related matters, environmental matters and intellectual property matters. The Company considers insurance coverage and third-party indemnification when determining required accruals for pending litigation and claims. Although the outcome of potential legal actions and claims cannot be determined, it is the Company's opinion, based on the information available, that it has adequate reserves for these liabilities.

Hetronic Germany-GmbH Matters

For several years, Hetronic Germany-GmbH and Hydronic-Steuersysteme-GmbH (the “Fuchs companies”) served as our distributors for Germany, Austria and other central and eastern European countries pursuant to their respective intellectual property licenses and distribution and assembly agreements. The Company became aware that the Fuchs companies and their managing director, Albert Fuchs, had materially violated those agreements. As a result, the Company terminated all of its agreements with the Fuchs companies. On June 20, 2014, the Company filed a lawsuit against the Fuchs companies in the Federal District Court for the Western District of Oklahoma alleging material breaches of the distribution and assembly agreements and seeking damages, as well as various forms of injunctive relief. The defendants filed counterclaims alleging breach of contract, interference with business relations and business slander. On April 2, 2015, the Company amended its complaint against the Fuchs companies to add additional unfair competition and Lanham Act claims and to add additional affiliated parties.

A trial with respect to the matter began in February 2020. During the trial, the defendants dismissed their one remaining counterclaim with prejudice. On March 2, 2020, the jury returned a verdict in favor of the Company. The verdict included approximately $102 million in compensatory damages and $11 million in punitive damages. On April 22, 2020, the District Court entered a permanent injunction barring defendants from selling infringing products and ordering them to return Hetronic’s confidential information. Defendants appealed entry of the permanent injunction. On May 29, 2020, the District Court held defendants in contempt for violating the permanent injunction and entered the final judgment. Defendants appealed entry of the final monetary judgment as well. The appeal of the permanent injunction and the appeal of the final judgment were consolidated into a single appeal before the U.S. Court of Appeals for the Tenth Circuit. On August 24, 2021, the Tenth Circuit issued a decision affirming the lower court’s ruling with the exception that it instructed the District Court to modify the injunction from the entire world to all of the countries in which Hetronic sells its products. On April 20 and 21, 2022, the District Court held a hearing related to modifying the injunction pursuant to the Tenth Circuit’s opinion, and the parties have filed post-hearing briefs. The defendants also filed a petition for certiorari with the United States Supreme Court seeking to further appeal the extraterritorial application of the Lanham Act in this case. The Company opposed that petition. The Supreme Court requested the views of the Solicitor General on the petition for certiorari, and the Solicitor General recommended granting the petition. On November 4, 2022, the Supreme Court granted the petition. The Supreme Court appeal currently is being briefed. No hearing date has yet been set. Like any judgment, particularly a judgment involving defendants outside of the United States, there is no guarantee that the Company will be able to collect all or any portion of the judgment.

21

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

As used herein, “we,” “us,” “our,” the “Company” or “Methode” means Methode Electronics, Inc. and its subsidiaries.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q (“Quarterly Report”) includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that reflect, when made, our current views with respect to current events and financial performance. Such forward-looking statements are subject to many risks, uncertainties and factors relating to our operations and business environment, which may cause our actual results to be materially different from any future results, express or implied, by such forward-looking statements. All statements that address future operating, financial or business performance or our strategies or expectations are forward-looking statements. In some cases, you can identify these statements by forward-looking words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “predicts,” “projects,” “potential,” “outlook” or “continue,” and other comparable terminology. Factors that could cause actual results to differ materially from these forward-looking statements include, but are not limited to, the following:

•
Dependence on our supply chain, including semiconductor suppliers;
•
Impact from pandemics, such as the COVID-19 pandemic;
•
Dependence on the automotive and commercial vehicle industries;
•
Impact from inflation;
•
Dependence on a small number of large customers, including one large automotive customer;
•
Dependence on the availability and price of materials;
•
Risks related to conducting global operations;
•
Ability to withstand pricing pressures, including price reductions;
•
Currency fluctuations;
•
Timing and magnitude of costs associated with restructuring activities;
•
Failure to attract and retain qualified personnel;
•
Recognition of goodwill and other intangible asset impairment charges;
•
Timing, quality and cost of new program launches;
•
International trade disputes resulting in tariffs and our ability to mitigate tariffs;
•
Adjustments to compensation expense for performance-based awards;
•
Investment in programs prior to the recognition of revenue;
•
Ability to compete effectively;
•
Impact from production delays or cancelled orders;
•
Ability to withstand business interruptions;
•
Ability to keep pace with rapid technological changes;
•
Breaches to our information technology systems;
•
Ability to avoid design or manufacturing defects;
•
Ability to manage our debt levels and any restrictions thereunder;
•
Income tax rate fluctuations;
•
Ability to protect our intellectual property;
•
Ability to successfully benefit from acquisitions and divestitures;
•
Impact from climate change and related regulations;
•
Judgments related to accounting for tax positions; and
•
Costs associated with environmental, health and safety regulations.

Additional details and factors are discussed under the caption “Risk Factors” in Part 1, Item 1A of our Annual Report on Form 10-K for the year ended April 30, 2022. New risks and uncertainties arise from time to time, and it is impossible for us to predict these events or how they may affect us. Any forward-looking statements made by us speak only as of the date on which they are made. We are under no obligation to, and expressly disclaim any obligation to, update or alter our forward-looking statements, whether as a result of new information, subsequent events or otherwise.

22

Table of Contents

Overview

We are a leading global supplier of custom engineered solutions with sales, engineering and manufacturing locations in North America, Europe, Middle East and Asia. We design, engineer and produce mechatronic products for Original Equipment Manufacturers (“OEMs”) utilizing our broad range of technologies for user interface, light-emitting diode (“LED”) lighting system, power distribution and sensor applications.

Our solutions are found in the end markets of transportation (including automotive, commercial vehicle, e-bike, aerospace, bus and rail), cloud computing infrastructure, construction equipment, consumer appliance and medical devices. Our business is managed on a segment basis, with those segments being Automotive, Industrial, Interface and Medical.

COVID-19 Pandemic Impact

The COVID-19 pandemic and the ongoing measures to reduce its spread have negatively impacted the global economy, disrupted consumer and customer demand and global supply chains, and resulted in manufacturing inefficiencies and increased freight costs due to global capacity constraints. Beginning late in the fourth quarter of fiscal 2022 and continuing into the first quarter of fiscal 2023, various regions in China, including regions where we and our customers have operations, were subjected to lock-downs imposed by governmental authorities to mitigate the spread of COVID-19 in those areas. The resulting industry-wide production interruptions adversely impacted our results of operations in the six months ended October 29, 2022.

Any future resurgence of COVID-19, and its related impacts, could negatively impact our business and future results of operations. The extent of the impact will depend on a number of evolving and uncertain factors, including the duration and spread of COVID-19 (and its variants), the rate of vaccinations, actions taken by governmental authorities to further restrict business operations and social activity and impose travel restrictions, shifting consumer demand, the ability of our supply chain to deliver in a timely and cost-effective manner, the ability of our employees and manufacturing facilities to operate efficiently and effectively, the continued viability and financial stability of our customers and suppliers and future access to capital. We continue to focus on effectively managing the unprecedented challenges and uncertainties of the pandemic on a global basis.

Global Supply Chain Disruptions

We continue to experience business interruptions, including customer shutdowns and increased material and logistics costs, labor shortages, and most significantly, impacts from the worldwide semiconductor supply shortage. The semiconductor supply shortage is due, in part, to increased demand across multiple industries, including the automotive industry, resulting in a slowdown in production schedules. The semiconductor supply shortage is also impacting our supply chain and our ability to meet demand at some of our non-automotive customers. We expect this semiconductor shortage to have a continued impact on our operating results and financial condition for the remainder of fiscal 2023.

Impacts of Macroeconomic and Geopolitical Conditions

Adverse macroeconomic conditions, including but not limited to inflation, slower growth or recession, new or increased tariffs, changes to fiscal and monetary policy, higher interest rates, wage and commodity inflation and currency fluctuations could adversely affect demand for our products. In addition, the Russia/Ukraine conflict has resulted in, among other things, economic sanctions imposed by the international community which have impacted the global economy and given rise to potential global security issues that may adversely affect international business and economic conditions. Although we have no operations in Russia or Ukraine, certain of our customers and suppliers have been negatively impacted by these events, which in turn has impacted markets where we do business, including Europe and Asia. The economic sanctions imposed on Russia have further increased existing global supply chain, logistics, and inflationary challenges. For example, in response to the sanctions imposed on Russia by Western countries, Russia has reduced the volume of natural gas it sends to European countries, which has resulted in, and could continue to result in increased energy costs for our EMEA operations. If Russia further reduces or turns off energy supplies to Europe, our EMEA operations could be adversely affected.

23

Table of Contents

Consolidated Results of Operations

The table below compares our results of operations between the three and six months ended October 29, 2022 and the three and six months ended October 30, 2021:

|  | Three Months Ended |  |  | Six Months Ended |
(in millions) |  | October 29, 2022 |  |  | October 30, 2021 |  |  | October 29, 2022 |  |  | October 30, 2021 |
Net sales |  | $ | 315.9 |  |  | $ | 295.5 |  |  | $ | 598.3 |  |  | $ | 583.3 |
Cost of products sold |  |  | 241.8 |  |  |  | 226.3 |  |  |  | 462.4 |  |  |  | 442.4 |
Gross profit |  |  | 74.1 |  |  |  | 69.2 |  |  |  | 135.9 |  |  |  | 140.9 |
Selling and administrative expenses |  |  | 36.6 |  |  |  | 31.2 |  |  |  | 71.9 |  |  |  | 64.0 |
Amortization of intangibles |  |  | 4.7 |  |  |  | 4.8 |  |  |  | 9.4 |  |  |  | 9.6 |
Interest expense, net |  |  | 0.5 |  |  |  | 1.1 |  |  |  | 0.5 |  |  |  | 2.2 |
Other income, net |  |  | (1.1 | ) |  |  | (0.9 | ) |  |  | (5.2 | ) |  |  | (2.7 | )
Income tax expense |  |  | 5.8 |  |  |  | 5.5 |  |  |  | 10.2 |  |  |  | 11.2 |
Net income |  | $ | 27.6 |  |  | $ | 27.5 |  |  | $ | 49.1 |  |  | $ | 56.6 |

Net sales

Net sales increased $20.4 million, or 6.9%, to $315.9 million in the three months ended October 29, 2022, compared to $295.5 million in the three months ended October 30, 2021. The increase was primarily due to higher sales in the Industrial segment, partially offset by lower sales in the Interface segment. Net sales were unfavorably impacted by foreign currency translation of $22.2 million, primarily due to the strengthening of the U.S. dollar relative to the euro and Chinese renminbi. Net sales included customer cost recoveries from spot buys of materials and premium freight costs of $5.8 million in the three months ended October 29, 2022, compared to $4.4 million in the three months ended October 30, 2021. Excluding the impact of foreign currency translation and customer cost recoveries, net sales increased $41.2 million, or 14.2%.

Net sales increased $15.0 million, or 2.6%, to $598.3 million in the six months ended October 29, 2022, compared to $583.3 million in the six months ended October 30, 2021. The increase was primarily due to higher sales in the Industrial segment, partially offset by lower sales in the Automotive segment. Net sales were unfavorably impacted by foreign currency translation of $36.5 million, primarily due to the strengthening of the U.S. dollar relative to the euro and Chinese renminbi. Net sales included customer cost recoveries from spot buys of materials and premium freight costs of $16.9 million in the six months ended October 29, 2022, compared to $4.5 million in the six months ended October 30, 2021. Excluding the impact of foreign currency translation and customer cost recoveries, net sales increased $39.1 million, or 6.8%.

Cost of products sold

Cost of products sold increased $15.5 million, or 6.8%, to $241.8 million (76.5% of net sales) in the three months ended October 29, 2022, compared to $226.3 million (76.6% of net sales) in the three months ended October 30, 2021. Excluding foreign currency translation, cost of products sold increased $32.2 million. The increase was primarily due to higher material costs of $29.5 million as a result of an increase in sales volumes and costs related to spot buys of materials.

Cost of products sold increased $20.0 million, or 4.5%, to $462.4 million (77.3% of net sales) in the six months ended October 29, 2022, compared to $442.4 million (75.8% of net sales) in the six months ended October 30, 2021. Excluding foreign currency translation, cost of products sold increased $46.9 million. The increase was primarily due to higher material costs of $42.4 million as a result of an increase in sales volumes and costs related to spot buys of materials.

Gross profit margin

Gross profit margin was 23.5% of net sales in the three months ended October 29, 2022, compared to 23.4% of net sales in the three months ended October 30, 2021. Gross margins remained steady as higher sales volumes offset higher material costs.

Gross profit margin was 22.7% of net sales in the six months ended October 29, 2022, compared to 24.2% of net sales in the six months ended October 30, 2021. The decrease was due to higher material and other costs associated with supply chain disruptions, partially offset by higher sales volumes.

24

Table of Contents

Selling and administrative expenses

Selling and administrative expenses increased $5.4 million, or 17.3%, to $36.6 million (11.6% of net sales) in the three months ended October 29, 2022, compared to $31.2 million (10.6% of net sales) in the three months ended October 30, 2021. Excluding foreign currency translation, selling and administrative expenses increased $7.0 million. The increase was primarily due to higher annual cash incentive compensation expense, professional fees and salary expense.

Selling and administrative expenses increased $7.9 million, or 12.3%, to $71.9 million (12.0% of net sales) in the six months ended October 29, 2022, compared to $64.0 million (11.0% of net sales) in the six months ended October 30, 2021. Excluding foreign currency translation, selling and administrative expenses increased $10.7 million. The increase was primarily due to higher annual cash incentive compensation expense, salary expense, professional fees and travel expense.

Amortization of intangibles

Amortization of intangibles was $4.7 million in the three months ended October 29, 2022, compared to $4.8 million in the three months ended October 30, 2021.

Amortization of intangibles was $9.4 million in the six months ended October 29, 2022, compared to $9.6 million in the six months ended October 30, 2021.

Interest expense, net

Interest expense, net was $0.5 million in the three months ended October 29, 2022, compared to $1.1 million in the three months ended October 30, 2021. The decrease was due to higher interest income of $0.8 million, partially offset by higher interest expense of $0.2 million recognized during the period. Higher interest income and interest expense was due to increasing interest rates.

Interest expense, net was $0.5 million in the six months ended October 29, 2022, compared to $2.2 million in the six months ended October 30, 2021. The decrease was due to higher interest income of $1.5 million primarily from our cash holdings as a result of increasing interest rates.

Other income, net

Other income, net was $1.1 million in the three months ended October 29, 2022, compared to $0.9 million in the three months ended October 30, 2021. Net foreign exchange gain was $0.9 million in the three months ended October 29, 2022, compared to a net foreign exchange loss of $1.2 million in the three months ended October 30, 2021. In the three months ended October 29, 2022, we received $0.2 million of international government assistance, compared to $2.1 million in the three months ended October 30, 2021.

Other income, net was $5.2 million in the six months ended October 29, 2022, compared to $2.7 million in the six months ended October 30, 2021. Net foreign exchange gain was $0.9 million in the six months ended October 29, 2022, compared to a net foreign exchange loss of $1.5 million in the six months ended October 30, 2021. In the six months ended October 29, 2022, we received $4.3 million of international government assistance with respect to the COVID-19 pandemic, compared to $4.0 million in the six months ended October 30, 2021.

Income tax expense

Income tax expense was $5.8 million (17.4% effective tax rate) in the three months ended October 29, 2022, compared to $5.5 million (16.7% effective tax rate) in the three months ended October 30, 2021. The effective tax rate for the three months ended October 29, 2022 was lower than the U.S. statutory tax rate primarily due to income derived from foreign operations with lower statutory tax rates and research deductions claimed in foreign jurisdictions, partially offset by non-deductible expenses. The effective tax rate for the three months ended October 30, 2021 was lower than the U.S. statutory tax rate primarily due to income derived from foreign operations with lower statutory tax rates.

Income tax expense was $10.2 million (17.2% effective tax rate) in the six months ended October 29, 2022, compared to $11.2 million (16.5% effective tax rate) in the six months ended October 30, 2021. The effective tax rate for the six months ended October 29, 2022 was lower than the U.S. statutory tax rate primarily due to income derived from foreign operations with lower statutory tax rates and research deductions claimed in foreign jurisdictions, partially offset by non-deductible expenses. The effective tax rate for the six months ended October 30, 2021 was lower than the U.S. statutory tax rate primarily due to income derived from foreign operations with lower statutory tax rates.

Net income

Net income increased $0.1 million, or 0.4%, to $27.6 million in the three months ended October 29, 2022, compared to $27.5 million in the three months ended October 30, 2021. Net income was unfavorably impacted by foreign currency translation of $3.4 million. Excluding foreign currency translation, net income increased $3.5 million as a result of the reasons described above.

25

Table of Contents

Net income decreased $7.5 million, or 13.3%, to $49.1 million in the six months ended October 29, 2022, compared to $56.6 million in the six months ended October 30, 2021. Net income was unfavorably impacted by foreign currency translation of $6.3 million. Excluding foreign currency translation, net income decreased $1.2 million as a result of the reasons described above.

Operating Segments

Automotive

|  | Three Months Ended |  |  | Six Months Ended |
($ in millions) |  | October 29, 2022 |  |  | October 30, 2021 |  |  | October 29, 2022 |  |  | October 30, 2021 |
Net sales |  |  |  |  |  |  |  |  |  |  |  |
North America |  | $ | 97.8 |  |  | $ | 99.3 |  |  | $ | 192.5 |  |  | $ | 198.4 |
EMEA |  |  | 53.9 |  |  |  | 54.9 |  |  |  | 106.0 |  |  |  | 112.7 |
Asia |  |  | 45.2 |  |  |  | 41.8 |  |  |  | 75.0 |  |  |  | 80.7 |
Net sales |  | $ | 196.9 |  |  | $ | 196.0 |  |  | $ | 373.5 |  |  | $ | 391.8 |
Gross profit |  | $ | 38.3 |  |  | $ | 37.2 |  |  | $ | 67.7 |  |  | $ | 78.9 |
As a percent of net sales |  |  | 19.5 | % |  |  | 19.0 | % |  |  | 18.1 | % |  |  | 20.1 | %
Income from operations |  | $ | 23.4 |  |  | $ | 23.6 |  |  | $ | 38.1 |  |  | $ | 50.9 |
As a percent of net sales |  |  | 11.9 | % |  |  | 12.0 | % |  |  | 10.2 | % |  |  | 13.0 | %
Customer cost recoveries: |  |  |  |  |  |  |  |  |  |  |  |
North America |  | $ | 1.5 |  |  | $ | 3.9 |  |  | $ | 9.4 |  |  | $ | 4.0 |
EMEA |  |  | 0.1 |  |  |  | — |  |  |  | 1.3 |  |  |  | — |
Asia |  |  | 0.6 |  |  |  | — |  |  |  | 0.6 |  |  |  | — |
Total |  | $ | 2.2 |  |  | $ | 3.9 |  |  | $ | 11.3 |  |  | $ | 4.0 |

Net sales

Automotive segment net sales increased $0.9 million, or 0.5%, to $196.9 million in the three months ended October 29, 2022, compared to $196.0 million in the three months ended October 30, 2021. Net sales were unfavorably impacted by foreign currency translation of $13.2 million. Excluding foreign currency translation and customer cost recoveries, net sales increased $15.8 million, or 8.2%.

Net sales in North America decreased $1.5 million to $97.8 million in the three months ended October 29, 2022, compared to $99.3 million in the three months ended October 30, 2021. Excluding customer cost recoveries, net sales increased $0.9 million primarily due to higher vehicle lighting product sales volumes, partially offset by lower sales volumes from a major program roll-off. Net sales in EMEA decreased $1.0 million to $53.9 million in the three months ended October 29, 2022, compared to $54.9 million in the three months ended October 30, 2021. The weaker euro, relative to the U.S. dollar, decreased net sales in EMEA by $9.5 million. Excluding foreign currency translation and customer cost recoveries, net sales in EMEA increased $8.4 million due to higher sales volumes. Net sales in Asia increased $3.4 million to $45.2 million in the three months ended October 29, 2022, compared to $41.8 million in the three months ended October 30, 2021. The weaker Chinese renminbi, relative to the U.S. dollar, decreased net sales in Asia by $3.6 million. Excluding foreign currency translation and customer cost recoveries, Asia net sales increased $6.4 million primarily due to higher electric vehicle product sales volumes, partially offset by lower touchscreen sales volumes.

Automotive segment net sales decreased $18.3 million, or 4.7%, to $373.5 million in the six months ended October 29, 2022, compared to $391.8 million in the six months ended October 30, 2021. Net sales were unfavorably impacted by foreign currency translation of $22.2 million and the roll-off of a major program in North America. Excluding foreign currency translation and customer cost recoveries, net sales decreased $3.4 million, or 0.9%.

Net sales in North America decreased $5.9 million to $192.5 million in the six months ended October 29, 2022, compared to $198.4 million in the six months ended October 30, 2021. Excluding customer cost recoveries, net sales decreased $11.3 million primarily due to a major program roll-off, partially offset by higher vehicle lighting product sales volumes. Net sales in EMEA decreased $6.7 million to $106.0 million in the six months ended October 29, 2022, compared to $112.7 million in the six months ended October 30, 2021. The weaker euro, relative to the U.S. dollar, decreased net sales in EMEA by $17.3 million. Excluding foreign currency translation and customer cost recoveries, net sales in EMEA increased $9.3 million due to higher sales volumes. Net sales in Asia decreased $5.7 million to $75.0 million in the six months ended October 29, 2022, compared to $80.7 million in the six months ended October 30, 2021. The weaker Chinese renminbi, relative to the U.S. dollar, decreased net sales in Asia by $4.9 million. Excluding foreign currency translation and customer cost recoveries, Asia net sales decreased $1.4 million primarily due to COVID-19 lockdowns in China in the first quarter of fiscal 2023.

26

Table of Contents

Gross profit

Automotive segment gross profit increased $1.1 million, or 3.0%, to $38.3 million in the three months ended October 29, 2022, compared to $37.2 million in the three months ended October 30, 2021. Excluding the impact of foreign currency translation, gross profit increased $4.0 million. Gross profit margins increased to 19.5% in the three months ended October 29, 2022, compared to 19.0% in the three months ended October 30, 2021. The increase in gross profit margins was due to higher sales volumes, which partially offset higher material and other costs due to inflationary pressures.

Automotive segment gross profit decreased $11.2 million, or 14.2%, to $67.7 million in the six months ended October 29, 2022, compared to $78.9 million in the six months ended October 30, 2021. Excluding the impact of foreign currency translation, gross profit decreased $6.1 million. Gross profit margins decreased to 18.1% in the six months ended October 29, 2022, compared to 20.1% in the six months ended October 30, 2021. The decrease in gross profit margins was due to lower sales volumes in the first quarter of fiscal 2023, higher material and other costs due to inflationary pressures and the impact from product mix.

Income from operations

Automotive segment income from operations decreased $0.2 million, or 0.8%, to $23.4 million in the three months ended October 29, 2022, compared to $23.6 million in the three months ended October 30, 2021. Excluding the impact of foreign currency translation, income from operations increased $1.4 million. The increase was primarily due to higher gross profit, partially offset by higher selling and administrative expenses. Selling and administrative expenses increased due to higher annual cash incentive compensation expense and salary expense as a result of wage inflation.

Automotive segment income from operations decreased $12.8 million, or 25.1%, to $38.1 million in the six months ended October 29, 2022, compared to $50.9 million in the six months ended October 30, 2021. Excluding the impact of foreign currency translation, income from operations decreased $9.9 million. The decrease was primarily due to lower gross profit and higher selling and administrative expenses. Selling and administrative expenses increased due to higher annual cash incentive compensation expense and salary expense as a result of wage inflation.

Industrial

|  | Three Months Ended |  |  | Six Months Ended |
($ in millions) |  | October 29, 2022 |  |  | October 30, 2021 |  |  | October 29, 2022 |  |  | October 30, 2021 |
Net sales |  | $ | 103.8 |  |  | $ | 80.7 |  |  | $ | 195.9 |  |  | $ | 159.2 |
Gross profit |  | $ | 33.3 |  |  | $ | 26.5 |  |  | $ | 63.7 |  |  | $ | 55.0 |
As a percent of net sales |  |  | 32.1 | % |  |  | 32.8 | % |  |  | 32.5 | % |  |  | 34.5 | %
Income from operations |  | $ | 25.0 |  |  | $ | 18.8 |  |  | $ | 47.4 |  |  | $ | 39.0 |
As a percent of net sales |  |  | 24.1 | % |  |  | 23.3 | % |  |  | 24.2 | % |  |  | 24.5 | %
Customer cost recoveries |  | $ | 2.5 |  |  | $ | 0.1 |  |  | $ | 3.9 |  |  | $ | 0.1 |

Net sales

Industrial segment net sales increased $23.1 million, or 28.6%, to $103.8 million in the three months ended October 29, 2022, compared to $80.7 million in the three months ended October 30, 2021. Net sales were unfavorably impacted by foreign currency translation of $9.0 million. Excluding the impact of foreign currency translation and customer cost recoveries, net sales increased $29.7 million, or 36.8%, primarily due to higher sales volumes of power distribution solutions for data centers and electric vehicles and commercial vehicle lighting solutions products.

Industrial segment net sales increased $36.7 million, or 23.1%, to $195.9 million in the six months ended October 29, 2022, compared to $159.2 million in the six months ended October 30, 2021. Net sales were unfavorably impacted by foreign currency translation of $14.3 million. Excluding the impact of foreign currency translation and customer cost recoveries, net sales increased $47.2 million, or 29.7%, primarily due to higher sales volumes of power distribution solutions for data centers and electric vehicles and by commercial vehicle lighting solutions products.

27

Table of Contents

Gross profit

Industrial segment gross profit increased $6.8 million, or 25.7%, to $33.3 million in the three months ended October 29, 2022, compared to $26.5 million in the three months ended October 30, 2021. Excluding the impact of foreign currency translation, gross profit increased $9.4 million. Gross profit margins decreased to 32.1% in the three months ended October 29, 2022, compared to 32.8% in the three months ended October 30, 2021. Product mix impacted gross margins due to higher material costs for commercial vehicle lighting solutions products, which was partially offset by higher gross margins for power distribution solutions for data centers and electric vehicles due to increased sales volumes.

Industrial segment gross profit increased $8.7 million, or 15.8%, to $63.7 million in the six months ended October 29, 2022, compared to $55.0 million in the six months ended October 30, 2021. Excluding the impact of foreign currency translation, gross profit increased $13.1 million. Gross profit margins decreased to 32.5% in the six months ended October 29, 2022, compared to 34.5% in the six months ended October 30, 2021. Product mix impacted gross margins primarily from higher material costs for commercial vehicle lighting solutions products as a result of supply chain disruptions.

Income from operations

Industrial segment income from operations increased $6.2 million, or 33.0%, to $25.0 million in the three months ended October 29, 2022, compared to $18.8 million in the three months ended October 30, 2021. Excluding the impact of foreign currency translation, income from operations increased $8.3 million. The increase was primarily due to higher gross profit, partially offset by a slight increase in selling and administrative expenses.

Industrial segment income from operations increased $8.4 million, or 21.5%, to $47.4 million in the six months ended October 29, 2022, compared to $39.0 million in the six months ended October 30, 2021. Excluding the impact of foreign currency translation, income from operations increased $12.0 million. The increase was primarily due to higher gross profit, partially offset by a slight increase in selling and administrative expenses.

Interface

|  | Three Months Ended |  |  | Six Months Ended |
($ in millions) |  | October 29, 2022 |  |  | October 30, 2021 |  |  | October 29, 2022 |  |  | October 30, 2021 |
Net sales |  | $ | 14.1 |  |  | $ | 18.0 |  |  | $ | 27.1 |  |  | $ | 30.7 |
Gross profit |  | $ | 2.5 |  |  | $ | 5.0 |  |  | $ | 4.7 |  |  | $ | 6.7 |
As a percent of net sales |  |  | 17.7 | % |  |  | 27.8 | % |  |  | 17.3 | % |  |  | 21.8 | %
Income from operations |  | $ | 1.6 |  |  | $ | 4.4 |  |  | $ | 3.2 |  |  | $ | 5.5 |
As a percent of net sales |  |  | 11.3 | % |  |  | 24.4 | % |  |  | 11.8 | % |  |  | 17.9 | %
Customer cost recoveries |  | $ | 1.1 |  |  | $ | 0.4 |  |  | $ | 1.7 |  |  | $ | 0.4 |

Net sales

Interface segment net sales decreased $3.9 million, or 21.7% to $14.1 million in the three months ended October 29, 2022, compared to $18.0 million in the three months ended October 30, 2021. Excluding customer cost recoveries, net sales decreased $4.6 million, or 26.1%. The decrease was primarily due to lower demand of appliance products.

Interface segment net sales decreased $3.6 million, or 11.7%, to $27.1 million in the six months ended October 29, 2022, compared to $30.7 million in the six months ended October 30, 2021. Excluding customer cost recoveries, net sales decreased $4.9 million, or 16.2%. The decrease was primarily due to lower demand of appliance products.

Gross profit

Interface segment gross profit decreased $2.5 million, or 50.0%, to $2.5 million in the three months ended October 29, 2022, compared to $5.0 million in the three months ended October 30, 2021. Gross profit margins decreased to 17.7% in the three months ended October 29, 2022, compared to 27.8% in the three months ended October 30, 2021. The decrease in gross profit margins was primarily due to lower sales volumes.

Interface segment gross profit decreased $2.0 million, or 29.9%, to $4.7 million in the six months ended October 29, 2022, compared to $6.7 million in the six months ended October 30, 2021. Gross profit margins decreased to 17.3% in the six months ended October 29, 2022, compared to 21.8% in the six months ended October 30, 2021. The decrease in gross profit margins was primarily due to lower sales volumes.

28

Table of Contents

Income from operations

Interface segment income from operations decreased $2.8 million, or 63.6%, to $1.6 million in the three months ended October 29, 2022, compared to $4.4 million in the three months ended October 30, 2021. The decrease was due to lower gross profit and slightly higher selling and administrative expenses.

Interface segment income from operations decreased $2.3 million, or 41.8%, to $3.2 million in the six months ended October 29, 2022, compared to $5.5 million in the six months ended October 30, 2021. The decrease was due to lower gross profit and slightly higher selling and administrative expenses.

Medical

|  | Three Months Ended |  |  | Six Months Ended |
(in millions) |  | October 29, 2022 |  |  | October 30, 2021 |  |  | October 29, 2022 |  |  | October 30, 2021 |
Net sales |  | $ | 1.1 |  |  | $ | 0.8 |  |  | $ | 1.8 |  |  | $ | 1.6 |
Gross profit |  | $ | (0.1 | ) |  | $ | (0.4 | ) |  | $ | (0.3 | ) |  | $ | (0.4 | )
Loss from operations |  | $ | (1.4 | ) |  | $ | (1.8 | ) |  | $ | (2.9 | ) |  | $ | (3.0 | )

Net sales

Medical segment net sales increased $0.3 million to $1.1 million in the three months ended October 29, 2022, compared to $0.8 million in the three months ended October 30, 2021. The increase was due to higher product acceptance.

Medical segment net sales increased $0.2 million to $1.8 million in the six months ended October 29, 2022, compared to $1.6 million in the six months ended October 30, 2021. The increase was due to higher product acceptance.

Gross profit

Medical segment gross profit was a loss of $0.1 million in the three months ended October 29, 2022 compared to a loss of $0.4 million in the three months ended October 30, 2021. The improvement was due to higher net sales, partially offset by higher operating costs in the three months ended October 29, 2022.

Medical segment gross profit was a loss of $0.3 million in the six months ended October 29, 2022 compared to a loss of $0.4 million in the six months ended October 30, 2021. The improvement was due to higher net sales, partially offset by higher operating costs in the six months ended October 29, 2022.

Loss from operations

Medical segment loss from operations decreased $0.4 million to $1.4 million in the three months ended October 29, 2022, compared to $1.8 million in the three months ended October 30, 2021. The decrease in the loss was primarily due to higher gross profit and slightly lower selling and administrative expenses.

Medical segment loss from operations decreased $0.1 million to $2.9 million in the six months ended October 29, 2022, compared to $3.0 million in the six months ended October 30, 2021. The decrease in the loss was primarily due to higher gross profit.

Financial Condition, Liquidity and Capital Resources

Our liquidity requirements are primarily to fund our business operations, including capital expenditures and working capital requirements, as well as to fund debt service requirements, dividends and stock repurchases. Our primary sources of liquidity are cash flows from operations, existing cash balances and borrowings under our senior unsecured credit agreement. We believe our liquidity position will be sufficient to fund our existing operations and current commitments for at least the next twelve months. However, if economic conditions remain impacted for longer than we expect due to the COVID-19 pandemic, supply chain disruptions, inflationary pressure or other geopolitical risks, including the Russia-Ukraine war, our liquidity position could be severely impacted.

As of October 29, 2022, we had $129.6 million of cash and cash equivalents, of which $86.1 million was held in subsidiaries outside the U.S. Cash held by these subsidiaries is used to fund operational activities and can be repatriated, primarily through the payment of dividends and the repayment of intercompany loans, without creating material additional income tax expense.

29

Table of Contents

Share Buyback Program

On March 31, 2021, the Board of Directors authorized the purchase of up to $100.0 million of our common stock. On June 16, 2022, the Board of Directors authorized an increase in the existing share buyback program of an additional $100.0 million, and extended the expiration of the program to June 14, 2024. Purchases may be made in private transactions or on the open market, including pursuant to purchase plans designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934. As of October 29, 2022, a total of 2,418,953 shares have been purchased at a total cost of $102.8 million since the commencement of the share buyback program. As of October 29, 2022, the dollar value of shares that remained available to be purchased under this share buyback program was $97.2 million.

Credit Agreement

On October 31, 2022, we entered into a Second Amended and Restated Credit Agreement (the “Credit Agreement”) with Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, and the Lenders and other parties named therein. The Credit Agreement amends and restates the Amended and Restated Credit Agreement, dated September 12, 2018 and as previously amended (the “Prior Credit Agreement”), with Bank of America, N.A., as Administrative Agent, Swing Line Lender, and L/C Issuer, Wells Fargo Bank, National Association, as L/C Issuer, and the Lenders named therein. Among other things, the Credit Agreement (i) increased the multicurrency revolving credit commitments under the Prior Credit Agreement to $750,000,000, (ii) refinanced in full and terminated the term loan facility under the Prior Credit Agreement, and (iii) made certain other changes to the covenants, terms, and conditions under the Prior Credit Agreement. In addition, the Credit Agreement permits us to increase the revolving commitments and/or add one or more tranches of term loans under the Credit Agreement from time to time by up to an amount equal to (i) $250,000,000 plus (ii) an additional amount so long as the leverage ratio would not exceed 3.00:1.00 on a pro forma basis, subject to, among other things, the receipt of additional commitments from existing and/or new lenders. The Credit Agreement terminates on October 31, 2027.

As of October 29, 2022, $200.0 million in principal was outstanding under the term loan under the Prior Credit Agreement. We were in compliance with all covenants under the Prior Credit Agreement as of October 29, 2022. For further information, see Note 7, “Debt” to the condensed consolidated financial statements included in this Quarterly Report.

Cash Flows

|  | Six Months Ended |
(in millions) |  | October 29, 2022 |  |  | October 30, 2021 |
Operating activities: |  |  |  |  |  |
Net income |  | $ | 49.1 |  |  | $ | 56.6 |
Non-cash items |  |  | 33.0 |  |  |  | 32.0 |
Changes in operating assets and liabilities |  |  | (54.0 | ) |  |  | (51.9 | )
Net cash provided by operating activities |  |  | 28.1 |  |  |  | 36.7 |
Net cash used in investing activities |  |  | (14.5 | ) |  |  | (20.7 | )
Net cash used in financing activities |  |  | (48.7 | ) |  |  | (69.7 | )
Effect of foreign currency exchange rate changes on cash and cash equivalents |  |  | (7.3 | ) |  |  | (2.3 | )
Decrease in cash and cash equivalents |  |  | (42.4 | ) |  |  | (56.0 | )
Cash and cash equivalents at beginning of the period |  |  | 172.0 |  |  |  | 233.2 |
Cash and cash equivalents at end of the period |  | $ | 129.6 |  |  | $ | 177.2 |

Operating activities

Net cash provided by operating activities decreased $8.6 million to $28.1 million in the six months ended October 29, 2022, compared to $36.7 million in the six months ended October 30, 2021. The decrease was due to lower net income adjusted for non-cash items. The $54.0 million of cash outflows for operating assets and liabilities in the six months ended October 29, 2022 was primarily due to higher accounts receivable and inventory, partially offset by higher accounts payable.

Investing activities

Net cash used in investing activities was $14.5 million in the six months ended October 29, 2022, compared to $20.7 million in the six months ended October 30, 2021. Capital expenditures were $18.0 million and $21.3 million in the six months ended October 29, 2022 and October 30, 2021, respectively. We received $3.5 million and $0.6 million of cash from the sale of property, plant and equipment in the six months ended October 29, 2022 and October 30, 2021, respectively.

30

Table of Contents

Financing activities

Net cash used in financing activities was $48.7 million in the six months ended October 29, 2022, compared to $69.7 million in the six months ended October 30, 2021. In the six months ended October 29, 2022, we used $31.6 million of cash for the purchase of shares under our share buyback program, compared to $42.5 million in the six months ended October 30, 2021. We paid cash dividends of $9.9 million in the six months ended October 29, 2022, compared to $10.3 million in the six months ended October 30, 2021. In the six months ended October 29, 2022, we had repayments on our borrowings of $6.5 million, compared to $16.8 million in the six months ended October 30, 2021.

Recent Accounting Pronouncements

See Note 1, “Description of Business and Summary of Significant Accounting Policies” to the condensed consolidated financial statements included in Item 1.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements as defined under SEC rules.

Legal Matters

For several years, Hetronic Germany-GmbH and Hydronic-Steuersysteme-GmbH (the “Fuchs companies”) served as our distributors for Germany, Austria and other central and eastern European countries pursuant to their respective intellectual property licenses and distribution and assembly agreements. We became aware that the Fuchs companies and their managing director, Albert Fuchs, had materially violated those agreements. As a result, we terminated all of our agreements with the Fuchs companies. On June 20, 2014, we filed a lawsuit against the Fuchs companies in the Federal District Court for the Western District of Oklahoma alleging material breaches of the distribution and assembly agreements and seeking damages, as well as various forms of injunctive relief. The defendants filed counterclaims alleging breach of contract, interference with business relations and business slander. On April 2, 2015, we amended our complaint against the Fuchs companies to add additional unfair competition and Lanham Act claims and to add additional affiliated parties.

A trial with respect to the matter began in February 2020. During the trial, the defendants dismissed their one remaining counterclaim with prejudice. On March 2, 2020, the jury returned a verdict in favor of the Company. The verdict included approximately $102 million in compensatory damages and $11 million in punitive damages. On April 22, 2020, the District Court entered a permanent injunction barring defendants from selling infringing products and ordering them to return Hetronic’s confidential information. Defendants appealed entry of the permanent injunction. On May 29, 2020, the District Court held defendants in contempt for violating the permanent injunction and entered the final judgment. Defendants appealed entry of the final monetary judgment as well. The appeal of the permanent injunction and the appeal of the final judgment were consolidated into a single appeal before the U.S. Court of Appeals for the Tenth Circuit. On August 24, 2021, the Tenth Circuit issued a decision affirming the lower court’s ruling with the exception that it instructed the District Court to modify the injunction from the entire world to all of the countries in which Hetronic sells its products. On April 20 and 21, 2022, the District Court held a hearing related to modifying the injunction pursuant to the Tenth Circuit’s opinion, and the parties have filed post-hearing briefs. The defendants also filed a petition for certiorari with the United States Supreme Court seeking to further appeal the extraterritorial application of the Lanham Act in this case. We opposed that petition. The Supreme Court requested the views of the Solicitor General on the petition for certiorari, and the Solicitor General recommended granting the petition. On November 4, 2022, the Supreme Court granted the petition. The Supreme Court appeal currently is being briefed. No hearing date has yet been set. Like any judgment, particularly a judgment involving defendants outside of the United States, there is no guarantee that we will be able to collect all or any portion of the judgment.

In the six months ended October 29, 2022 and October 30, 2021, we incurred Hetronic-related legal fees of $1.4 million and $3.5 million, respectively. These amounts are included in the selling and administrative expenses in the Industrial segment.

31

Table of Contents

Item 3. Quantitative and Qualitat ive Disclosures About Market Risk

We are exposed to market risks from foreign currency exchange, interest rates, and commodity prices, which could affect our operating results, financial position and cash flows. We manage a portion of these risks through use of derivative financial instruments in accordance with our policies. We do not enter into derivative financial instruments for speculative or trading purposes.

There has been no significant change in our exposure to market risk during the six months ended October 29, 2022. For a discussion of our exposure to market risk, refer to Item 7A, “Quantitative and Qualitative Disclosures about Market Risk,” contained in our Annual Report on Form 10-K for the year ended April 30, 2022.

Item 4. Controls and Procedures

As of the end of the period covered by this quarterly report on Form 10-Q, we performed an evaluation under the supervision and with the participation of the Company’s management, including our Chief Executive Officer and our Chief Financial Officer, of our “disclosure controls and procedures” (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934). The Company’s disclosure controls and procedures are designed to ensure that the information required to be disclosed by the Company in the reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s applicable rules and forms. As a result of this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this report, the Company’s disclosure controls and procedures were effective.

There have been no changes in our internal control over financial reporting during the quarter ended October 29, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

32

Table of Contents

PART II. OTHER INFORMATION

Item 1A. Ri sk Factors

Our business, financial condition, results of operations and cash flows are subject to various ‎risks which could cause actual results to vary from recent results or from anticipated future results. There have ‎been no material changes to the risk factors previously disclosed in Part I - Item 1A, “Risk Factors” of our Form 10-K for the ‎year ended April 30, 2022.‎

Item 2. Unregister ed Sales of Equity Securities and Use of Proceeds

On March 31, 2021, the Board of Directors authorized the purchase of up to $100.0 million of the Company’s outstanding common stock through March 31, 2023. On June 16, 2022, the Board of Directors authorized an increase in the share buyback program of an additional $100.0 million, and extended the expiration of the program to June 14, 2024. Purchases may be made in private transactions or on the open market, including pursuant to purchase plans designed to comply with Rule 10b5-1 of the Securities Exchange Act of 1934. As of October 29, 2022, we purchased and retired $102.8 million of common stock since the commencement of the share buyback program.

The following table provides information about our purchases of equity securities during the three months ended October 29, 2022:

Period |  | Total number of shares purchased |  |  | Average price paid per share |  |  | Total number of shares purchased as part of publicly announced plan |  |  | Approximate dollar value of shares that may yet be purchased under the program (in millions) |
July 31, 2022 through August 27, 2022 |  |  | 81,000 |  |  | $ | 42.02 |  |  |  | 81,000 |  |  | $ | 113.5 |
August 28, 2022 through October 1, 2022 |  |  | 361,374 |  |  | $ | 38.13 |  |  |  | 361,374 |  |  | $ | 99.7 |
October 2, 2022 through October 29, 2022 |  |  | 65,805 |  |  | $ | 37.68 |  |  |  | 65,805 |  |  | $ | 97.2 |

Item 6. Exhibits

Exhibit Number |  | Description
10.1 |  | Methode Electronics, Inc. 2022 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on September 14, 2022).
31.1 |  | Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer.
31.2 |  | Rule 13a-14(a)/15d-14(a) Certification of Principal Financial Officer.
32* |  | Certification of Periodic Financial Report Pursuant to 18 U.S.C. Section 1350.
101.INS |  | Inline XBRL Instance Document
101.SCH |  | Inline XBRL Taxonomy Extension Schema Document
101.CAL |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF |  | Inline XBRL Taxonomy Extension Definition Document
101.LAB |  | Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document
104 |  | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
* |  | Indicates that the exhibit is being furnished with this report and not filed as part of it.

33

Table of Contents

SIGNAT URES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

|  |  |  | METHODE ELECTRONICS, INC.
|  |  |  | By: |  | /s/ Ronald L.G. Tsoumas
|  |  |  |  |  | Ronald L.G. Tsoumas
|  |  |  |  |  | Chief Financial Officer
|  |  |  |  |  | (Principal Financial Officer)
Dated: |  | December 1, 2022 |  |  |  |

34